JPH07316002A - Water-based preparation for thermal dissipation, thermal dissipation method and volatility-controlling agent for water-based preparation for thermal dissipation - Google Patents
Water-based preparation for thermal dissipation, thermal dissipation method and volatility-controlling agent for water-based preparation for thermal dissipationInfo
- Publication number
- JPH07316002A JPH07316002A JP6092845A JP9284594A JPH07316002A JP H07316002 A JPH07316002 A JP H07316002A JP 6092845 A JP6092845 A JP 6092845A JP 9284594 A JP9284594 A JP 9284594A JP H07316002 A JPH07316002 A JP H07316002A
- Authority
- JP
- Japan
- Prior art keywords
- aqueous
- drug
- water
- heat
- evaporation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 57
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 55
- 238000000034 method Methods 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract 6
- 238000001704 evaporation Methods 0.000 claims abstract description 89
- 230000008020 evaporation Effects 0.000 claims abstract description 63
- 238000010438 heat treatment Methods 0.000 claims abstract description 57
- 239000003960 organic solvent Substances 0.000 claims abstract description 53
- -1 diol compound Chemical class 0.000 claims abstract description 39
- 239000000126 substance Substances 0.000 claims abstract description 33
- 239000003814 drug Substances 0.000 claims description 122
- 229940079593 drug Drugs 0.000 claims description 108
- 239000007788 liquid Substances 0.000 claims description 39
- 239000002250 absorbent Substances 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 14
- 238000009834 vaporization Methods 0.000 claims description 14
- 230000008016 vaporization Effects 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 12
- 239000013043 chemical agent Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 abstract description 8
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 230000017525 heat dissipation Effects 0.000 abstract 1
- 238000002207 thermal evaporation Methods 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 description 36
- 239000003921 oil Substances 0.000 description 30
- 235000019198 oils Nutrition 0.000 description 30
- 230000002745 absorbent Effects 0.000 description 29
- 239000000243 solution Substances 0.000 description 20
- 239000000654 additive Substances 0.000 description 19
- 239000002904 solvent Substances 0.000 description 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 230000005068 transpiration Effects 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 230000000996 additive effect Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- XLOPRKKSAJMMEW-SFYZADRCSA-M (R,R)-chrysanthemate Chemical compound CC(C)=C[C@@H]1[C@@H](C([O-])=O)C1(C)C XLOPRKKSAJMMEW-SFYZADRCSA-M 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 239000011230 binding agent Substances 0.000 description 7
- 239000003381 stabilizer Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 239000002023 wood Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000005871 repellent Substances 0.000 description 5
- 230000002940 repellent Effects 0.000 description 5
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 5
- OEGPRYNGFWGMMV-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC OEGPRYNGFWGMMV-UHFFFAOYSA-N 0.000 description 4
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 4
- CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 4
- 239000003125 aqueous solvent Substances 0.000 description 4
- 239000010425 asbestos Substances 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 4
- 239000002781 deodorant agent Substances 0.000 description 4
- PFRGXCVKLLPLIP-UHFFFAOYSA-N diallyl disulfide Chemical compound C=CCSSCC=C PFRGXCVKLLPLIP-UHFFFAOYSA-N 0.000 description 4
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000004445 quantitative analysis Methods 0.000 description 4
- 229910052895 riebeckite Inorganic materials 0.000 description 4
- ZCVAOQKBXKSDMS-PVAVHDDUSA-N (+)-trans-(S)-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-PVAVHDDUSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 229960001901 bioallethrin Drugs 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Chemical compound C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000000749 insecticidal effect Effects 0.000 description 3
- 239000002917 insecticide Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- CSZZMFWKAQEMPB-UHFFFAOYSA-N 1-methoxybutan-2-ol Chemical compound CCC(O)COC CSZZMFWKAQEMPB-UHFFFAOYSA-N 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N 2-methoxyethyl acetate Chemical compound COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 2
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 2
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- FHUODBDRWMIBQP-UHFFFAOYSA-N Ethyl p-anisate Chemical compound CCOC(=O)C1=CC=C(OC)C=C1 FHUODBDRWMIBQP-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000000642 acaricide Substances 0.000 description 2
- 229940022663 acetate Drugs 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229940007550 benzyl acetate Drugs 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- 239000010632 citronella oil Substances 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- FXHGMKSSBGDXIY-UHFFFAOYSA-N heptanal Chemical compound CCCCCCC=O FXHGMKSSBGDXIY-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000012784 inorganic fiber Substances 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- TZMFJUDUGYTVRY-UHFFFAOYSA-N pentane-2,3-dione Chemical group CCC(=O)C(C)=O TZMFJUDUGYTVRY-UHFFFAOYSA-N 0.000 description 2
- 229960000490 permethrin Drugs 0.000 description 2
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N propiophenone Chemical compound CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 229960002447 thiram Drugs 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- ZCVAOQKBXKSDMS-AQYZNVCMSA-N (+)-trans-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-AQYZNVCMSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- SBNFWQZLDJGRLK-RTWAWAEBSA-N (1R)-trans-phenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-RTWAWAEBSA-N 0.000 description 1
- LLMLSUSAKZVFOA-UJURSFKZSA-N (1S,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@@H]1C(O)=O LLMLSUSAKZVFOA-UJURSFKZSA-N 0.000 description 1
- ZHHYXNZJDGDGPJ-BSWSSELBSA-N (2e,4e)-nona-2,4-dienal Chemical compound CCCC\C=C\C=C\C=O ZHHYXNZJDGDGPJ-BSWSSELBSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- AQWRXTQESBVJPN-UHFFFAOYSA-N (3,5-dimethyl-4-methylsulfanylphenyl)-methylcarbamic acid Chemical compound CSC1=C(C)C=C(N(C)C(O)=O)C=C1C AQWRXTQESBVJPN-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- SODPIMGUZLOIPE-UHFFFAOYSA-N (4-chlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1 SODPIMGUZLOIPE-UHFFFAOYSA-N 0.000 description 1
- VEMKTZHHVJILDY-PMACEKPBSA-N (5-benzylfuran-3-yl)methyl (1r,3s)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-PMACEKPBSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- NQBWNECTZUOWID-UHFFFAOYSA-N (E)-cinnamyl (E)-cinnamate Natural products C=1C=CC=CC=1C=CC(=O)OCC=CC1=CC=CC=C1 NQBWNECTZUOWID-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 1
- WQRWNOKNRHCLHV-TWGQIWQCSA-N (z)-2-bromo-3-phenylprop-2-enal Chemical compound O=CC(/Br)=C/C1=CC=CC=C1 WQRWNOKNRHCLHV-TWGQIWQCSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- JLIDRDJNLAWIKT-UHFFFAOYSA-N 1,2-dimethyl-3h-benzo[e]indole Chemical compound C1=CC=CC2=C(C(=C(C)N3)C)C3=CC=C21 JLIDRDJNLAWIKT-UHFFFAOYSA-N 0.000 description 1
- WIHIUTUAHOZVLE-UHFFFAOYSA-N 1,3-diethoxypropan-2-ol Chemical compound CCOCC(O)COCC WIHIUTUAHOZVLE-UHFFFAOYSA-N 0.000 description 1
- KVGZZAHHUNAVKZ-UHFFFAOYSA-N 1,4-Dioxin Chemical compound O1C=COC=C1 KVGZZAHHUNAVKZ-UHFFFAOYSA-N 0.000 description 1
- PWMWNFMRSKOCEY-UHFFFAOYSA-N 1-Phenyl-1,2-ethanediol Chemical compound OCC(O)C1=CC=CC=C1 PWMWNFMRSKOCEY-UHFFFAOYSA-N 0.000 description 1
- GZEYORSRDNLAPB-UHFFFAOYSA-N 1-butoxybutan-2-ol Chemical compound CCCCOCC(O)CC GZEYORSRDNLAPB-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- XFNJVKMNNVCYEK-UHFFFAOYSA-N 1-naphthaleneacetamide Chemical compound C1=CC=C2C(CC(=O)N)=CC=CC2=C1 XFNJVKMNNVCYEK-UHFFFAOYSA-N 0.000 description 1
- JMBWBOKFMJWVCU-UHFFFAOYSA-N 1-phenylethanone;tetradecanoic acid Chemical compound CC(=O)C1=CC=CC=C1.CCCCCCCCCCCCCC(O)=O JMBWBOKFMJWVCU-UHFFFAOYSA-N 0.000 description 1
- HFZLSTDPRQSZCQ-UHFFFAOYSA-N 1-pyrrolidin-3-ylpyrrolidine Chemical compound C1CCCN1C1CNCC1 HFZLSTDPRQSZCQ-UHFFFAOYSA-N 0.000 description 1
- FMTFEIJHMMQUJI-NJAFHUGGSA-N 102130-98-3 Natural products CC=CCC1=C(C)[C@H](CC1=O)OC(=O)[C@@H]1[C@@H](C=C(C)C)C1(C)C FMTFEIJHMMQUJI-NJAFHUGGSA-N 0.000 description 1
- ZWBANJRSWNLUEP-UHFFFAOYSA-N 2,2,2-trichloro-1,1-bis(2-chlorophenyl)ethanol Chemical compound C=1C=CC=C(Cl)C=1C(C(Cl)(Cl)Cl)(O)C1=CC=CC=C1Cl ZWBANJRSWNLUEP-UHFFFAOYSA-N 0.000 description 1
- YPZMPEPLWKRVLD-UHFFFAOYSA-N 2,3,4,5,6,7-hexahydroxyheptanal Chemical compound OCC(O)C(O)C(O)C(O)C(O)C=O YPZMPEPLWKRVLD-UHFFFAOYSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- BVUXDWXKPROUDO-UHFFFAOYSA-N 2,6-di-tert-butyl-4-ethylphenol Chemical compound CCC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 BVUXDWXKPROUDO-UHFFFAOYSA-N 0.000 description 1
- SLUKQUGVTITNSY-UHFFFAOYSA-N 2,6-di-tert-butyl-4-methoxyphenol Chemical compound COC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 SLUKQUGVTITNSY-UHFFFAOYSA-N 0.000 description 1
- UPTVJAJPBGIRLZ-UHFFFAOYSA-N 2-(trichloromethylsulfanyl)-3a,4,5,7a-tetrahydroisoindole-1,3-dione Chemical compound C1CC=CC2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C21 UPTVJAJPBGIRLZ-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- RCSBILYQLVXLJG-UHFFFAOYSA-N 2-Propenyl hexanoate Chemical compound CCCCCC(=O)OCC=C RCSBILYQLVXLJG-UHFFFAOYSA-N 0.000 description 1
- QVTWQIWXCYMFQI-CZDSEFAFSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;trihydrochloride Chemical compound Cl.Cl.Cl.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QVTWQIWXCYMFQI-CZDSEFAFSA-N 0.000 description 1
- COBPKKZHLDDMTB-UHFFFAOYSA-N 2-[2-(2-butoxyethoxy)ethoxy]ethanol Chemical compound CCCCOCCOCCOCCO COBPKKZHLDDMTB-UHFFFAOYSA-N 0.000 description 1
- ZDRBJJNXJOSCLR-YZKQBBCCSA-N 2-amino-2-[(2r,3s,5s,6r)-5-amino-2-methyl-6-[(2r,3s,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxyoxan-3-yl]iminoacetic acid;hydron;chloride Chemical compound Cl.N[C@H]1C[C@H](N=C(N)C(O)=O)[C@@H](C)O[C@@H]1OC1[C@H](O)[C@@H](O)C(O)[C@H](O)[C@@H]1O ZDRBJJNXJOSCLR-YZKQBBCCSA-N 0.000 description 1
- QGLVWTFUWVTDEQ-UHFFFAOYSA-N 2-chloro-3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1Cl QGLVWTFUWVTDEQ-UHFFFAOYSA-N 0.000 description 1
- DVCHJFSLGUNEQZ-UHFFFAOYSA-M 2-ethenyl-2,6-dimethylhept-5-enoate Chemical compound CC(C)=CCCC(C)(C=C)C([O-])=O DVCHJFSLGUNEQZ-UHFFFAOYSA-M 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- GCYHRYNSUGLLMA-UHFFFAOYSA-N 2-prop-2-enoxyethanol Chemical compound OCCOCC=C GCYHRYNSUGLLMA-UHFFFAOYSA-N 0.000 description 1
- HXIQYSLFEXIOAV-UHFFFAOYSA-N 2-tert-butyl-4-(5-tert-butyl-4-hydroxy-2-methylphenyl)sulfanyl-5-methylphenol Chemical compound CC1=CC(O)=C(C(C)(C)C)C=C1SC1=CC(C(C)(C)C)=C(O)C=C1C HXIQYSLFEXIOAV-UHFFFAOYSA-N 0.000 description 1
- IMOYOUMVYICGCA-UHFFFAOYSA-N 2-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C=C1C(C)(C)C IMOYOUMVYICGCA-UHFFFAOYSA-N 0.000 description 1
- MQBGNZBSQKLFQG-UHFFFAOYSA-N 3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethyl-1-[(2,3,5,6-tetrafluoro-4-methylphenyl)methyl]cyclopropane-1-carboxylic acid Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1CC1(C(O)=O)C(C)(C)C1C=C(Cl)C(F)(F)F MQBGNZBSQKLFQG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- ZIMFYUVBZDZPGP-UHFFFAOYSA-N 3-methoxy-2-methylbutan-1-ol Chemical compound COC(C)C(C)CO ZIMFYUVBZDZPGP-UHFFFAOYSA-N 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- DTMSIDXRHPAAHJ-UHFFFAOYSA-N 3-nitro-1-phenyl-1-(pyridin-3-ylmethyl)urea Chemical compound C=1C=CC=CC=1N(C(=O)N[N+](=O)[O-])CC1=CC=CN=C1 DTMSIDXRHPAAHJ-UHFFFAOYSA-N 0.000 description 1
- ZWYZHNNHSZXTTG-UHFFFAOYSA-N 3-pentyloxolan-2-one Chemical compound CCCCCC1CCOC1=O ZWYZHNNHSZXTTG-UHFFFAOYSA-N 0.000 description 1
- 239000001636 3-phenylprop-2-enyl 3-phenylprop-2-enoate Substances 0.000 description 1
- XNYGOEGATLFFOX-UHFFFAOYSA-N 4,5a,6,9,9a,9b-hexahydro-1h-dibenzofuran-4a-carbaldehyde Chemical compound C12CC=CCC2OC2(C=O)C1CC=CC2 XNYGOEGATLFFOX-UHFFFAOYSA-N 0.000 description 1
- NYVOHOMXFQGCCT-UHFFFAOYSA-N 4-(2,2-dimethylhydrazinyl)-4-oxobutanamide Chemical compound CN(C)NC(=O)CCC(N)=O NYVOHOMXFQGCCT-UHFFFAOYSA-N 0.000 description 1
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 1
- OALYTRUKMRCXNH-UHFFFAOYSA-N 5-pentyloxolan-2-one Chemical compound CCCCCC1CCC(=O)O1 OALYTRUKMRCXNH-UHFFFAOYSA-N 0.000 description 1
- YLDDCEXDGNXCIO-UHFFFAOYSA-N 6-ethoxy-2,2,4-trimethyl-3,4-dihydro-1h-quinoline Chemical compound N1C(C)(C)CC(C)C2=CC(OCC)=CC=C21 YLDDCEXDGNXCIO-UHFFFAOYSA-N 0.000 description 1
- PIVQQUNOTICCSA-UHFFFAOYSA-N ANTU Chemical compound C1=CC=C2C(NC(=S)N)=CC=CC2=C1 PIVQQUNOTICCSA-UHFFFAOYSA-N 0.000 description 1
- 241000218642 Abies Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- YPQSPODHFDGVAC-UHFFFAOYSA-N Butyl heptanoate Chemical compound CCCCCCC(=O)OCCCC YPQSPODHFDGVAC-UHFFFAOYSA-N 0.000 description 1
- VHSIHRPVNUGWEO-UHFFFAOYSA-N C(N)(OC)=O.C(N)(OC)=O.[Zn] Chemical compound C(N)(OC)=O.C(N)(OC)=O.[Zn] VHSIHRPVNUGWEO-UHFFFAOYSA-N 0.000 description 1
- MHDAIZAJLWVJDU-UHFFFAOYSA-N C1(CCC(C)O1)=O.C1(CC(CC)O1)=O Chemical compound C1(CCC(C)O1)=O.C1(CC(CC)O1)=O MHDAIZAJLWVJDU-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- NQBWNECTZUOWID-MZXMXVKLSA-N Cinnamyl cinnamate Chemical compound C=1C=CC=CC=1/C=C/C(=O)OC\C=C\C1=CC=CC=C1 NQBWNECTZUOWID-MZXMXVKLSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ULSLJYXHZDTLQK-UHFFFAOYSA-N Coumatetralyl Chemical group C1=CC=CC2=C1OC(=O)C(C1C3=CC=CC=C3CCC1)=C2O ULSLJYXHZDTLQK-UHFFFAOYSA-N 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 239000005764 Dithianon Substances 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 235000008227 Illicium verum Nutrition 0.000 description 1
- 240000007232 Illicium verum Species 0.000 description 1
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 1
- WVRPFQGZHKZCEB-UHFFFAOYSA-N Isopropyl 2-methylpropanoate Chemical compound CC(C)OC(=O)C(C)C WVRPFQGZHKZCEB-UHFFFAOYSA-N 0.000 description 1
- RMOUBSOVHSONPZ-UHFFFAOYSA-N Isopropyl formate Chemical compound CC(C)OC=O RMOUBSOVHSONPZ-UHFFFAOYSA-N 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- JBVVONYMRFACPQ-UHFFFAOYSA-N Linalylformate Natural products CC(=C)CCCC(C)(OC=O)C=C JBVVONYMRFACPQ-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000006001 Methyl nonyl ketone Substances 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- DJNTZVRUYMHBTD-UHFFFAOYSA-N Octyl octanoate Chemical compound CCCCCCCCOC(=O)CCCCCCC DJNTZVRUYMHBTD-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- IAFYECQOAFBBPN-UHFFFAOYSA-N P(=S)(OC)(OC)OC1=CC(=C(C=C1)[N+](=O)[O-])C.CNC(O)=O Chemical compound P(=S)(OC)(OC)OC1=CC(=C(C=C1)[N+](=O)[O-])C.CNC(O)=O IAFYECQOAFBBPN-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- LQKRYVGRPXFFAV-UHFFFAOYSA-N Phenylmethylglycidic ester Chemical compound CCOC(=O)C1OC1(C)C1=CC=CC=C1 LQKRYVGRPXFFAV-UHFFFAOYSA-N 0.000 description 1
- RZKYEQDPDZUERB-UHFFFAOYSA-N Pindone Chemical compound C1=CC=C2C(=O)C(C(=O)C(C)(C)C)C(=O)C2=C1 RZKYEQDPDZUERB-UHFFFAOYSA-N 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- 239000005843 Thiram Substances 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- KMPQYAYAQWNLME-UHFFFAOYSA-N Undecanal Natural products CCCCCCCCCCC=O KMPQYAYAQWNLME-UHFFFAOYSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- ZKLAMYCHKQQIAH-UHFFFAOYSA-N [Zn].[Zn].C(N)(SCCSC(N)=S)=S.CN(C(S)=S)C.CN(C(S)=S)C Chemical compound [Zn].[Zn].C(N)(SCCSC(N)=S)=S.CN(C(S)=S)C.CN(C(S)=S)C ZKLAMYCHKQQIAH-UHFFFAOYSA-N 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229940024113 allethrin Drugs 0.000 description 1
- 239000001068 allium cepa oil Substances 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- HMKKIXGYKWDQSV-KAMYIIQDSA-N alpha-Amylcinnamaldehyde Chemical compound CCCCC\C(C=O)=C\C1=CC=CC=C1 HMKKIXGYKWDQSV-KAMYIIQDSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- JOSWYUNQBRPBDN-UHFFFAOYSA-P ammonium dichromate Chemical compound [NH4+].[NH4+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O JOSWYUNQBRPBDN-UHFFFAOYSA-P 0.000 description 1
- 239000001408 angelica archangelica l. root oil Substances 0.000 description 1
- IMHBYKMAHXWHRP-UHFFFAOYSA-N anilazine Chemical compound ClC1=CC=CC=C1NC1=NC(Cl)=NC(Cl)=N1 IMHBYKMAHXWHRP-UHFFFAOYSA-N 0.000 description 1
- KDYBROJIAHWOPC-UHFFFAOYSA-N anthracene-9,10-dione;pyridin-4-amine Chemical compound NC1=CC=NC=C1.C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 KDYBROJIAHWOPC-UHFFFAOYSA-N 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- WAKZZMMCDILMEF-UHFFFAOYSA-H barium(2+);diphosphate Chemical compound [Ba+2].[Ba+2].[Ba+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O WAKZZMMCDILMEF-UHFFFAOYSA-H 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- DULCUDSUACXJJC-UHFFFAOYSA-N benzeneacetic acid ethyl ester Natural products CCOC(=O)CC1=CC=CC=C1 DULCUDSUACXJJC-UHFFFAOYSA-N 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 1
- 229960002836 biphenylol Drugs 0.000 description 1
- ZFRJWHPIBHEPHL-UHFFFAOYSA-N bis(methylsulfanyl)carbamodithioic acid Chemical compound CSN(SC)C(S)=S ZFRJWHPIBHEPHL-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 229960000411 camphor oil Drugs 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229950009941 chloralose Drugs 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 235000020057 cognac Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 229960001826 dimethylphthalate Drugs 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- USPVNSDVCUTNJN-UHFFFAOYSA-N ethenyl cyclopropanecarboxylate Chemical compound C=COC(=O)C1CC1 USPVNSDVCUTNJN-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 239000011094 fiberboard Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000010647 garlic oil Substances 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 1
- GCXZDAKFJKCPGK-UHFFFAOYSA-N heptane-1,2-diol Chemical compound CCCCCC(O)CO GCXZDAKFJKCPGK-UHFFFAOYSA-N 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- QCIYAEYRVFUFAP-UHFFFAOYSA-N hexane-2,3-diol Chemical compound CCCC(O)C(C)O QCIYAEYRVFUFAP-UHFFFAOYSA-N 0.000 description 1
- MWVFCEVNXHTDNF-UHFFFAOYSA-N hexane-2,3-dione Chemical group CCCC(=O)C(C)=O MWVFCEVNXHTDNF-UHFFFAOYSA-N 0.000 description 1
- POFSNPPXJUQANW-UHFFFAOYSA-N hexane-3,4-diol Chemical compound CCC(O)C(O)CC POFSNPPXJUQANW-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229940024423 isopropyl isobutyrate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000001748 laurus nobilis l. leaf oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 229940107698 malachite green Drugs 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- HNWOBVZNHRIPQH-UHFFFAOYSA-N methane;octadecyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound C.CCCCCCCCCCCCCCCCCCOC(=O)CCC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 HNWOBVZNHRIPQH-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- IJXHLVMUNBOGRR-UHFFFAOYSA-N methyl nonanoate Chemical compound CCCCCCCCC(=O)OC IJXHLVMUNBOGRR-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- FHJRFIYKPIXQNQ-UHFFFAOYSA-N n,n-diethyloctanamide Chemical compound CCCCCCCC(=O)N(CC)CC FHJRFIYKPIXQNQ-UHFFFAOYSA-N 0.000 description 1
- XRARAKHBJHWUHW-QVUBZLTISA-N neoline Chemical compound O[C@@H]1[C@H]2[C@@H]3[C@@]4([C@@H]5[C@H]6OC)[C@@H](O)CC[C@@]5(COC)CN(CC)C4[C@H]6[C@@]2(O)C[C@H](OC)[C@H]1C3 XRARAKHBJHWUHW-QVUBZLTISA-N 0.000 description 1
- HTSYYNWISWGUIR-UHFFFAOYSA-N neoline Natural products CCN1CC2(COc3ccccc3)CCC(O)C45C6CC7C(CC(O)(C6C7O)C(C(OC)C24)C15)OC HTSYYNWISWGUIR-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- XLMFDCKSFJWJTP-UHFFFAOYSA-N pentane-2,3-diol Chemical compound CCC(O)C(C)O XLMFDCKSFJWJTP-UHFFFAOYSA-N 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960003536 phenothrin Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- QXJKBPAVAHBARF-UHFFFAOYSA-N procymidone Chemical compound O=C1C2(C)CC2(C)C(=O)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- LFULEKSKNZEWOE-UHFFFAOYSA-N propanil Chemical compound CCC(=O)NC1=CC=C(Cl)C(Cl)=C1 LFULEKSKNZEWOE-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 1
- 229940108410 resmethrin Drugs 0.000 description 1
- VEMKTZHHVJILDY-FIWHBWSRSA-N resmethrin Chemical compound CC1(C)[C@H](C=C(C)C)C1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-FIWHBWSRSA-N 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000003128 rodenticide Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- XJZGOPCKLSQXRM-UHFFFAOYSA-M sodium acetate hydrofluoride Chemical compound [Na+].C(C)(=O)O.[F-] XJZGOPCKLSQXRM-UHFFFAOYSA-M 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- XRARAKHBJHWUHW-UHFFFAOYSA-N subcusine Natural products OC1C2C3C4(C5C6OC)C(O)CCC5(COC)CN(CC)C4C6C2(O)CC(OC)C1C3 XRARAKHBJHWUHW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- CXBMCYHAMVGWJQ-UHFFFAOYSA-N tetramethrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-UHFFFAOYSA-N 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 229960005080 warfarin Drugs 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
- 239000013053 water resistant agent Substances 0.000 description 1
- 238000009333 weeding Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、加熱による薬剤の蒸散
に用いる加熱蒸散剤において、安全性等を改善した加熱
蒸散用水性薬剤、その水性薬剤を用いた加熱蒸散方法及
び薬液の蒸散が長時間円滑に行われるための加熱蒸散用
水性薬剤の揮散性調整剤並びに該揮散性調整剤による加
熱蒸散用水性薬剤の揮散性を調整する方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a heat-evaporating agent used for evaporating a medicine by heating, an aqueous medicine for heat-evaporation having improved safety, a heat-evaporation method using the aqueous medicine, and a long evaporation of a liquid medicine. The present invention relates to a volatility adjusting agent for an aqueous chemical agent for heating and evaporation, which is performed smoothly over time, and a method for adjusting the volatility of the aqueous chemical agent for heating and evaporating by the volatility adjusting agent.
【0002】[0002]
【従来の技術】従来より殺虫、消臭、賦香、殺菌等の目
的で之等の薬剤を加熱蒸散させる方法としては、古くは
蚊取線香のように点火してその熱で薬剤を蒸散させる方
法があり、この方法に次いで火を使わない方法として、
電気蒸散器具等の装置を用いて繊維板等の多孔質基材
(固型マット)に吸着させた薬剤を加熱して蒸散させる
方法が開発されて、汎用されている。しかしながら、該
方法では装置の構造が簡単であるという利点はあるが、
一枚の固型マットに含浸させ得る薬剤量は自ずと制限を
受け、長期に亙る安定した薬剤揮散効果を持続させ得
ず、該マットの取替え及び使用済マットの廃棄が必須で
ある等の欠点がある。2. Description of the Related Art Conventionally, as a method for heating and evaporating such chemicals for the purpose of insecticidal, deodorant, aromatizing, sterilizing, etc., in the old days, the chemicals are evaporated by the heat by igniting like a mosquito coil. There is a method, and as a method that does not use fire next to this method,
A method for heating and evaporating a drug adsorbed on a porous base material (solid mat) such as a fiber board using a device such as an electric evaporation device has been developed and widely used. However, although the method has the advantage that the structure of the device is simple,
The amount of drug that can be impregnated into one solid mat is naturally limited, and it is not possible to maintain a stable drug volatilization effect for a long period of time, and it is necessary to replace the mat and dispose of the used mat. is there.
【0003】上記固型マット使用に見られるマット取替
えの問題及び短時間内に効果が消失する欠点を解消し、
長期に亙り薬剤の揮散効果を持続させ得る加熱蒸散方法
として、該薬剤を溶液形態で吸上芯(吸液芯)により吸
上げつつこれを加熱蒸散させる方法が考えられ、事実こ
のような吸液芯利用による薬剤蒸散装置が種々提案され
ている。これら装置は適当な容器に薬剤の溶剤溶液(薬
液)を入れ、これをフエルト等の吸液芯を利用して吸上
げつつ該吸液芯上部より加熱蒸散させるべくしたもので
ある。The problem of mat replacement and the defect that the effect disappears within a short period of time, which is found in the use of the solid mat, is solved,
As a heating evaporation method capable of maintaining the volatilization effect of a drug over a long period of time, a method in which the drug is heated and evaporated while being sucked up by a wick (absorption core) in the form of a solution is conceivable. Various chemical vaporization devices using a wick have been proposed. In these devices, a solvent solution (medicine solution) of a drug is put in an appropriate container, which is sucked up by using an absorbent core such as felt and is heated and evaporated from above the absorbent core.
【0004】このような吸液芯利用による薬剤蒸散装置
には、薬液として一般に前記の薬剤を有機溶媒に溶解し
たものが使用されている。これは、前記の薬剤が一般に
有機化合物であって、有機溶媒に溶解しやすいため所定
濃度の溶液を容易に形成できることと、有機溶媒は蒸発
しやすいため、その蒸発により薬剤の揮散を容易にする
という利点があることによるものである。特に、その有
機溶媒としては、広く石油系溶剤、例えば灯油等が使用
されている。しかし、これらの有機溶媒は燃えやすいた
め、危険であり、製品の貯蔵・運搬に問題があり、また
有機溶媒は蒸発しやすいために薬剤よりも先に揮散して
しまい、かなりの量の薬剤が未揮散のまま残るという問
題がある。[0004] In such a chemical vaporization device utilizing a liquid-wicking core, as the chemical liquid, the above-mentioned chemicals dissolved in an organic solvent are generally used. This is because the above-mentioned drug is generally an organic compound and can be easily dissolved in an organic solvent to form a solution having a predetermined concentration, and since the organic solvent is easily evaporated, the evaporation facilitates the volatilization of the drug. This is due to the advantage. In particular, petroleum-based solvents such as kerosene are widely used as the organic solvent. However, since these organic solvents are flammable, they are dangerous, and there is a problem in storage and transportation of the product.Because the organic solvents easily evaporate, they volatilize before the drug, and a considerable amount of drug is There is a problem that it remains undissolved.
【0005】これらの欠点を除くため、薬液を水を溶媒
としたもの、すなわち水性薬剤とすることが考えられて
いる。しかし、前記の薬剤は通常水溶性でないため、水
を溶媒とする薬液を形成させるのには、通常例えば薬剤
を水中に溶解させるのを助長させる作用を有するか、あ
るいはそれ自体が薬剤を溶解し、その溶液が水に溶ける
というような作用を有する添加剤の類を加えるなどの何
らかの手段が必要である。噴霧用殺虫剤等についても水
性薬剤が知られていて、それには種々の添加剤が用いら
れているが、この加熱蒸散に使用する水性薬剤について
も同様な手段が必要である。特開平3−7207号公報
には、水性殺虫剤を形成するために、添加剤として、1
00〜180℃で加熱温度で蒸散するという、特定の界
面活性剤を用いることが示され、そのような界面活性剤
としては、例えば非イオン型のポリオキシアルキレンア
ルキルエーテル系化合物、非イオン型のポリオキシアル
キレンフェニルエーテル系化合物、ポリオキシエチレン
脂肪酸エステル、多価アルコール脂肪酸部分エステル、
多価アルコール部分エステル、ポリオキシエチレンポリ
オキシプロピルグリコール等が挙げられている。In order to eliminate these drawbacks, it has been considered to use a drug solution containing water as a solvent, that is, an aqueous drug. However, since the above-mentioned drugs are usually not water-soluble, forming a drug solution using water as a solvent usually has the action of, for example, facilitating dissolution of the drug in water, or the drug itself dissolves the drug. However, some means such as adding a kind of additive having an action such that the solution dissolves in water is necessary. Aqueous chemicals are known as spraying insecticides and the like, and various additives are used for them, but similar means are also necessary for the aqueous chemicals used for this heat evaporation. Japanese Patent Application Laid-Open No. 3-7207 discloses that as an additive for forming an aqueous insecticide, 1
It has been shown to use a specific surfactant that evaporates at a heating temperature of 00 to 180 ° C. Examples of such a surfactant include a nonionic polyoxyalkylene alkyl ether compound and a nonionic type Polyoxyalkylene phenyl ether compound, polyoxyethylene fatty acid ester, polyhydric alcohol fatty acid partial ester,
Partial polyhydric alcohol esters, polyoxyethylene polyoxypropyl glycol and the like are mentioned.
【0006】[0006]
【発明が解決しようとする課題】しかしながら、加熱蒸
散用水性薬剤としては、水及び殺虫化合物との溶剤の
相溶性、加熱蒸散時の蒸散性、の2つ大きな問題点を
解決しなければならない。とりわけについては、加熱
蒸散用水性薬剤を吸液芯を使用して加熱蒸散させた場合
に、蒸散開始から20日間を過ぎると急激に有効揮散率
が低下する現象を生じるが、これは芯の目詰まりが起き
ているものと考えられ、このため吸液芯を使用する加熱
蒸散方法を20日間以上の長期にわたり使用するには適
さなかった。加熱蒸散用水性薬剤を使用する場合におい
ても、油性有機溶剤を用いている従来の加熱蒸散用薬剤
と同程度の期間、長期にわたって使用できることが要求
される。そのために、長期にわたって使用できる溶剤、
添加剤などの選択、或いはその組成割合の選定を行うこ
とが必要である。However, as the aqueous agent for heat evaporation, two major problems must be solved: compatibility of the solvent with water and insecticidal compound, and evaporation property during heat evaporation. In particular, when the aqueous agent for heat evaporation is heated and evaporated using an absorbent core, a phenomenon in which the effective volatilization rate sharply decreases after 20 days from the start of evaporation occurs, but this is It is considered that clogging occurred, and therefore, the heat evaporation method using the absorbent core was not suitable for long-term use of 20 days or more. Even in the case of using the water chemical for heat evaporation, it is required that it can be used for a long period as long as the conventional chemicals for heat evaporation using an oily organic solvent. Therefore, a solvent that can be used for a long time,
It is necessary to select additives and the like, or the composition ratio thereof.
【0007】本発明は、前記の問題点を解決した加熱蒸
散用水性薬剤、及びそれを使用する加熱蒸散方法を提供
することを目的とするものである。本発明は、前記吸液
芯で加熱蒸散させる際に、目詰まりを生ずることがな
い、吸液芯における薬剤の蒸散が安定して継続され、そ
の蒸散を長時間低下させることがないように持続するよ
うにできる加熱蒸散用水性薬剤、及びそれを使用する加
熱蒸散方法を提供することを目的とするものである。さ
らに本発明の目的は、前記吸液芯で加熱蒸散させる際
に、目詰まりを生ずることがなく、吸液芯において薬剤
が安定してかつ均一に蒸散する状態が継続でき、その均
一な蒸散状態を長時間変化させることがないように持続
するようにできる揮散性調整剤及び加熱蒸散用水性薬剤
の揮散性を調整する方法を提供することを目的とするも
のである。本発明は、加熱蒸散用水性薬剤において用い
る溶剤として水性溶剤を使用して水性薬剤の形成を容易
にする場合に、前記の問題点が生じない水性溶剤を選択
して使用しようとすることを目的とするものである。ま
た本発明は、加熱蒸散用水性薬剤に添加する揮散性調整
剤の成分として、水性有機化合物を使用して効果的な揮
散性調整剤の形成を容易にする特定の水性有機化合物を
選択して使用しようとすることを目的とするものであ
る。An object of the present invention is to provide an aqueous chemical agent for heating and transpiration which solves the above problems, and a heating and transpiration method using the same. The present invention, when heating and evaporating with the liquid-wicking wick, does not cause clogging, the transpiration of the drug in the liquid-wicking wick is continued stably, and the transpiration does not decrease for a long time. It is an object of the present invention to provide a heat-evaporable aqueous agent that can be prepared as described above and a heat-evaporation method using the same. Further, the object of the present invention, when heating and evaporating with the absorbent core, without causing clogging, it is possible to continue the state of stable and uniform evaporation of the drug in the absorbent core, the uniform evaporation state It is an object of the present invention to provide a method for adjusting the volatility of a volatile property adjusting agent and a volatile property of a water-based chemical agent for heat vaporization, which can be maintained without changing for a long time. The present invention is intended to select and use an aqueous solvent that does not cause the above-mentioned problems when facilitating the formation of an aqueous drug by using the aqueous solvent as a solvent used in an aqueous drug for heat evaporation. It is what Further, the present invention, by selecting a specific aqueous organic compound that facilitates the formation of an effective volatility adjusting agent by using an aqueous organic compound as a component of the volatility adjusting agent added to the aqueous agent for heat evaporation. It is intended to be used.
【0008】[0008]
【課題を解決するための手段】本発明者は、前記した目
的を達成するために、加熱蒸散用水性薬剤の成分薬液に
種々の水性溶剤を構成成分として加えてその蒸散性や吸
液芯における目詰まりに及ぼす影響を鋭意研究した結
果、(1)有効成分の加熱蒸散性薬剤を有機溶剤と水と
共に含有する加熱蒸散用水性薬剤において、分子量が7
5〜170の水性有機溶剤を6〜60重量%と水を94
〜40重量%とを含有することを特徴とする加熱蒸散用
水性薬剤を提供し、(2)有効成分の加熱蒸散性薬剤、
分子量が75〜170の水性有機溶剤を6〜60重量%
及び水を94〜40重量%を含有する加熱蒸散用水性薬
剤を40〜450℃の温度で加熱して蒸散させることを
特徴とする加熱蒸散方法により、蒸散性薬剤の蒸散が安
定して継続され、その蒸散を長時間低下させることがな
いという前記の目的を達成した。本発明者は、さらに研
究を重ねた結果、(3)水性ジオール系化合物、水性ア
ルコール系化合物の少なくともいずれか一方を主成分と
して含有することを特徴とする加熱蒸散用水性薬剤の揮
散性調整剤により、それを添加した加熱蒸散用水性薬剤
を提供し、(4)水性ジオール系化合物、水性アルコー
ル系化合物の少なくともいずれか一方を含有させること
を特徴とする加熱蒸散用水性薬剤の揮散性を調整する方
法により、吸液芯において薬剤が安定してかつ均一に蒸
散する状態が継続でき、その均一な蒸散状態を長時間変
化させることがないという理想的な加熱蒸散法を達成す
るに到った。Means for Solving the Problems In order to achieve the above-mentioned object, the present inventors have added various aqueous solvents as constituent components to the component chemicals of an aqueous drug for heat vaporization to improve its transpiration property and liquid absorption core. As a result of diligent research into the effect on clogging, (1) a heat-evaporable aqueous drug containing an active ingredient, a heat-evaporable drug, together with an organic solvent and water, has a molecular weight of 7
5 to 170% aqueous organic solvent 6 to 60% by weight and water 94
To 40% by weight, and (2) a heat-evaporable drug as an active ingredient,
6 to 60% by weight of an aqueous organic solvent having a molecular weight of 75 to 170
And a water-evaporating aqueous drug containing 94 to 40% by weight of water is heated at a temperature of 40 to 450 ° C. to evaporate, thereby stably evaporating the evaporative drug. The above-mentioned object that the transpiration is not reduced for a long time has been achieved. As a result of further research by the present inventor, (3) a volatility adjusting agent for an aqueous drug for heat evaporation characterized by containing at least one of an aqueous diol compound and an aqueous alcohol compound as a main component. To provide a water agent for heating and evaporating, and (4) adjust the volatility of the water agent for heating and evaporating, which contains at least one of an aqueous diol compound and an aqueous alcohol compound. By the method described above, the state in which the drug is stably and uniformly evaporated in the absorbent core can be continued, and an ideal heating evaporation method in which the uniform evaporation state is not changed for a long time has been achieved. .
【0009】本発明の加熱蒸散用水性薬剤及び揮散性調
整剤を用いた加熱蒸散用水性薬剤は、吸液芯を用いた加
熱蒸散装置において加熱蒸散する際に、吸液芯の目詰ま
りを生じることなく、薬剤の揮散が長時間安定して行う
ことができる。また、この加熱蒸散用水性薬剤は比較的
低い温度で加熱することにより、長時間に亘って薬剤の
揮散を持続させることができる。また、揮散性調整剤を
用いた加熱蒸散用水性薬剤は通電後期においても、加熱
蒸散用水性薬剤の組成の変化が少なく、液の白濁を生じ
ない、さらに比較的低い温度で加熱することにより、長
時間にわたって全期間均一に薬剤の揮散を持続させるこ
とができる。[0009] The aqueous agent for heating and evaporation using the aqueous agent for heating and evaporation and the volatility adjusting agent of the present invention causes clogging of the absorbent core when it is evaporated by heating in a heating and evaporation apparatus using an absorbent core. The chemical can be volatilized stably for a long time. Further, by heating the aqueous agent for heat evaporation at a relatively low temperature, it is possible to keep the agent volatilizing for a long time. Further, the heating-evaporating aqueous agent using the volatility adjusting agent, even in the latter stage of energization, has little change in the composition of the heating-evaporating aqueous agent, does not cause cloudiness of the liquid, and is heated at a relatively low temperature, It is possible to maintain the volatilization of the drug evenly over the long term.
【0010】本発明において用いる分子量が75〜17
0の水性有機溶剤としては、具体的には、2−メチル−
2,4−ペンタンジオール、フェニルエチレングリコー
ル、ネオペンチルグリコール、1,6−ヘキサメチレン
グリコール、1,2−ヘキサンジオール、1,2−ペン
タンジオール、2−メトキシエチルアセテート、β−バ
レロラクトン(4−バレロラクトン)、γ−ブチロラク
トン、2−メチル−3−メトキシブタノール、1−メト
キシ−2−ブタノール、3−メトキシ−3−メチルブタ
ノール、ベラトリルアルコール(3,4−ジメトキシベ
ンジルアルコール)、3−メチル−1,5−ペンタンジ
オール、ジアセトンアルコール、アセトイン、ジエチリ
ンが挙げられ、これらの1種又は2種以上を用いること
ができる。また、前記の水性溶剤として、前記の物質の
外に、他のグリコール類やその他の親水性溶剤を使用す
ることができ、このようなグリコール類としては、エチ
レングリコール、プロピレングリコール、ブチレングリ
コール、スチレングリコール、アリルグリコール、ブチ
ルジグリコール、イソブチルジグリコール、ブチルトリ
グリコールなどが挙げられる。The molecular weight used in the present invention is 75 to 17
As the aqueous organic solvent of 0, specifically, 2-methyl-
2,4-Pentanediol, phenylethylene glycol, neopentyl glycol, 1,6-hexamethylene glycol, 1,2-hexanediol, 1,2-pentanediol, 2-methoxyethyl acetate, β-valerolactone (4- Valerolactone), γ-butyrolactone, 2-methyl-3-methoxybutanol, 1-methoxy-2-butanol, 3-methoxy-3-methylbutanol, veratryl alcohol (3,4-dimethoxybenzyl alcohol), 3-methyl Examples include -1,5-pentanediol, diacetone alcohol, acetoin, and diethylin, and one or more of these can be used. In addition to the substance, other glycols and other hydrophilic solvents can be used as the aqueous solvent, and such glycols include ethylene glycol, propylene glycol, butylene glycol, and styrene. Examples thereof include glycol, allyl glycol, butyl diglycol, isobutyl diglycol and butyl triglycol.
【0011】本発明において用いる水性ジオール系化合
物、水性アルコール系化合物(以下これらを水性有機化
合物という。)としては、1,2−プロパンジオール、
1,2−ブタンジオール、2,3−ブタンジオール、
1,2−ペンタンジオール、2,3−ペンタンジオー
ル、1,2−ヘキサンジオール、2,3−ヘキサンジオ
ール、3,4−ヘキサンジオール、1,2−ヘプタンジ
オール、1−メトキシ−2−プロパノール、1−エトキ
シ−2−プロパノール、1−ブトキシ−2−プロパノー
ル、1−メトキシ−2−ブタノール、1−ブトキシ−2
−ブタノールなどが挙げられ、本発明の加熱蒸散用水性
薬剤の揮散性調整剤には、これら水性有機化合物の1種
または2種以上を用いる。好ましい水性有機化合物とし
ては、一般式(1)に示されるように、隣接した位置に
親水性基(水酸基、アルコキシ基等)をもつ、親水性と
親油性の両性の性質を有したものが良い。The aqueous diol compounds and aqueous alcohol compounds (hereinafter referred to as aqueous organic compounds) used in the present invention include 1,2-propanediol,
1,2-butanediol, 2,3-butanediol,
1,2-pentanediol, 2,3-pentanediol, 1,2-hexanediol, 2,3-hexanediol, 3,4-hexanediol, 1,2-heptanediol, 1-methoxy-2-propanol, 1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1-methoxy-2-butanol, 1-butoxy-2
-Butanol and the like are used, and one or more of these aqueous organic compounds are used as the volatility adjusting agent of the aqueous agent for heat evaporation of the present invention. As a preferable aqueous organic compound, as shown in the general formula (1), a compound having a hydrophilic group (hydroxyl group, alkoxy group, etc.) at adjacent positions and having amphiphilic property of hydrophilicity and lipophilicity is preferable. .
【0012】[0012]
【化1】 [Chemical 1]
【0013】一般式(1)中R1 及びR4 はHまたはC
の数が1〜6の有機基、R2 及びR3 はHまたはCの数
が1〜3の有機基である。本発明の加熱蒸散用水性薬剤
の揮散性調整剤において、前記水性有機化合物はエチレ
ングリコール、プロピレングリコール、ヘキシレングリ
コール等のグリコール類、ブチルジグリコール、イソブ
チルジグリコール等のグリコールエーテル類、プロパノ
ール、ブタノール等のアルコール類の親水性溶剤との併
用として使用することも可能である。なお、前記一般式
(1)で表される水性有機化合物のうち、特に好ましい
のは、末端に親水性基を有する、すなわちR1 のCの数
がゼロ(すなわち水素原子)で、R4 のCの数が1〜6
で、R2 +R3 のCの数が1〜3または両方とも水素原
子の場合であり、これらは薬剤にも水にも十分に可溶化
し、粘性も高くなく、凝固点も低く、沸点の面において
も使用する上で優れている。前記水性有機化合物の中に
は、加熱蒸散用水性薬剤に加える水性有機溶剤として用
いられ得る有機化合物も含まれる。なお、本発明の加熱
蒸散用水性薬剤における前記水性有機溶剤と水との含有
割合は水性薬剤中の割合で規定すると、加熱蒸散性薬剤
の量などにより変動するので、前記水性有機溶剤と水と
の合計量に対するそれぞれの百分率で示している。ま
た、本発明の揮散性調整剤を添加した加熱蒸散用水性薬
剤中における前記水性有機化合物と水との含有割合は水
性薬剤中の割合で規定すると、加熱蒸散性薬剤の有効成
分の量などにより変動するので、前記水性有機化合物と
水との合計量に対するそれぞれの百分率で示している。
水性薬剤中のこれらの水性有機溶剤の含有割合は、その
組み合わせる組成成分により異なるが、例えば水性薬剤
の6〜40重量%の範囲が好ましい。また、水性薬剤中
のこれらの水性有機化合物の含有割合は、その組み合わ
せる組成成分により異なるが、例えば水性薬剤の6〜4
0重量%の範囲が好ましい。In the general formula (1), R 1 and R 4 are H or C
Is an organic group having 1 to 6 and R 2 and R 3 are organic groups having 1 to 3 H or C. In the volatility adjuster of the aqueous agent for heat evaporation of the present invention, the aqueous organic compound is a glycol such as ethylene glycol, propylene glycol, or hexylene glycol, a glycol ether such as butyldiglycol or isobutyldiglycol, propanol, butanol. It is also possible to use it in combination with a hydrophilic solvent such as alcohol. Of the above general formula (1) an aqueous organic compound represented by particular preference, ends having a hydrophilic group, i.e., the number of R 1 C at zero (i.e., a hydrogen atom), the R 4 The number of C is 1 to 6
In the case where the number of Cs in R 2 + R 3 is 1 to 3 or both are hydrogen atoms, and these are sufficiently solubilized in both the drug and water, the viscosity is not high, the freezing point is low, and the boiling point is small. It is also excellent for use in. The above-mentioned aqueous organic compound also includes an organic compound that can be used as an aqueous organic solvent added to the aqueous agent for heat evaporation. Incidentally, the content ratio of the aqueous organic solvent and water in the heat-evaporable aqueous drug of the present invention is defined by the ratio in the aqueous drug, since it varies depending on the amount of the heat-evaporable drug and the like, the aqueous organic solvent and water. Is shown as a percentage of the total amount. Further, when the content ratio of the aqueous organic compound and water in the heat-evaporable aqueous drug to which the volatility adjusting agent of the present invention is added is defined by the ratio in the aqueous drug, it depends on the amount of the active ingredient of the heat-evaporable drug and the like. Since it varies, it is shown as a percentage of the total amount of the aqueous organic compound and water.
The content ratio of these aqueous organic solvents in the aqueous drug varies depending on the composition components to be combined, but is preferably in the range of 6 to 40% by weight of the aqueous drug. The content ratio of these aqueous organic compounds in the aqueous drug varies depending on the composition components to be combined, but is, for example, 6 to 4 of the aqueous drug.
A range of 0% by weight is preferred.
【0014】本発明の加熱蒸散用水性薬剤に含有させる
有効成分としての加熱蒸散用薬剤としては、従来より殺
虫、消臭、賦香、殺菌、忌避、防黴、植物生長調節、除
草、殺ダニ等に用いられている各種薬剤をいずれも使用
することができる。それらの具体例としては、以下のも
のを例示できる。 (殺虫・殺ダニ剤) ・3−アリル−2−メチルシクロペンタ−2−エン−4
−オン−1−イル dl−シス/トランス−クリサンテ
マート(一般名アレスリン:商品名ピナミン:住友化学
工業株式会社製,アレスリンの異性体:商品名エスビオ
ール) ・3−アリル−2−メチルシクロペンタ−2−エン−4
−オン−1−イル d−シス/トランス−クリサンテマ
ート(商品名ピナミンフォルテ:住友化学工業株式会社
製) ・d−3−アリル−2−メチルシクロペンタ−2−エン
−4−オン−1−イルd−トランス−クリサンテマート
(商品名エキスリン:住友化学工業株式会社製) ・3−アリル−2−メチルシクロペンタ−2−エン−4
−オン−1−イル d−トランス−クリサンテマート
(一般名バイオアレスリン、以下ADという) ・N−(3,4,5,6−テトラヒドロフタリミド)−
メチル dl−シス/トランス−クリサンテマート(一
般名フタルスリン:商品名ネオピナミン:住友化学工業
株式会社製)The heat-evaporating agent as an active ingredient to be contained in the aqueous agent for heat-evaporating of the present invention has conventionally been insecticidal, deodorant, perfuming, bactericidal, repellent, antifungal, plant growth control, weeding, acaricide. Any of various drugs used in the above can be used. The following can be illustrated as specific examples thereof. (Insecticide / miticide) 3-allyl-2-methylcyclopent-2-ene-4
-On-1-yl dl-cis / trans-chrysanthemate (generic name arethrin: trade name pinamine: manufactured by Sumitomo Chemical Co., Ltd., isomer of allethrin: trade name esbiol) 3-allyl-2-methylcyclopenta -2-En-4
-On-1-yl d-cis / trans-chrysanthemate (trade name Pinamine Forte: manufactured by Sumitomo Chemical Co., Ltd.) d-3-allyl-2-methylcyclopent-2-en-4-one- 1-yl d-trans-chrysanthate (trade name: Exulin: manufactured by Sumitomo Chemical Co., Ltd.) 3-allyl-2-methylcyclopent-2-ene-4
-On-1-yl d-trans-chrysanthemate (generic name bioallethrin, hereinafter referred to as AD) N- (3,4,5,6-tetrahydrophthalimide)-
Methyl dl-cis / trans-chrysanthemate (generic name Phthathrin: trade name neopinamine: Sumitomo Chemical Co., Ltd.)
【0015】・5−ベンジル−3−フリルメチル d−
シス/トランス−クリサンテマート(一般名レスメトリ
ン:商品名クリスロンフォルテ:住友化学工業株式会社
製) ・5−(2−プロパルギル)−3−フリルメチル クリ
サンテマート(一般名フラメトリン) ・3−フェノキシベンジル 2,2−ジメチル−3−
(2′,2′−ジクロロ)ビニルシクロプロパン カル
ボキシレート(一般名ペルメトリン:商品名エクスミ
ン:住友化学工業株式会社製) ・3−フェノキシベンジル d−シス/トランス−クリ
サンテマート(一般名フェノトリン:商品名スミスリ
ン:住友化学工業株式会社製) ・α−シアノフェノキシベンジル イソプロピル−4−
クロロフェニルアセテート(一般名フェンバレレート:
商品名スミサイジン、住友化学工業株式会社製)5-benzyl-3-furylmethyl d-
Cis / trans-chrysanthemate (generic name resmethrin: trade name kryslonforte: manufactured by Sumitomo Chemical Co., Ltd.) 5- (2-propargyl) -3-furylmethyl chrysanthemate (generic name flamethrin) 3-phenoxy Benzyl 2,2-dimethyl-3-
(2 ', 2'-dichloro) vinylcyclopropane carboxylate (generic name permethrin: trade name Exmine: Sumitomo Chemical Co., Ltd.) 3-phenoxybenzyl d-cis / trans-chrysanthemate (generic name phenothrin: trade name Name Smith Lin: Sumitomo Chemical Co., Ltd.) ・ α-cyanophenoxybenzyl isopropyl-4-
Chlorophenyl acetate (generic name fenvalerate:
(Product name Sumicidin, Sumitomo Chemical Co., Ltd.)
【0016】・d−2−メチル−4−オキソ−3−プロ
パルギルシクロペント−2−エニルd−シス/トランス
−クリサンテマート(一般名d,d−T80−プラレト
リン:商品名エトック、住友化学工業株式会社製) ・2,3,5,6−テトラフルオロ−4−メチルベンジ
ル−3−(2´−クロロ−3´,3´,3´−トリフル
オロ−1−プロペニル)−2,2−ジメチルシクロプロ
パンカルボキシレート(一般名テフルスリン) ・2,3,5,6−テトラフルオロベンジル−3−
(2,2−ジクロロビニル)−2,2−ジメチルシクロ
プロパンカルボキシレート(一般名ベンフルスリン) ・(S)−α−シアノ−3−フェノキシベンジル (1
R,シス)−3−(2,2−ジクロロビニル)−2,2
−ジメチルシクロプロパンカルボキシレート ・(R,S)−α−シアノ−3−フェノキシベンジル
(1R,1S)−シス/トランス−3−(2,2−ジク
ロロビニル)−2,2−ジメチルシクロプロパンカルボ
キシレート ・α−シアノ−3−フェノキシベンジル d−シス/ト
ランス−クリサンテマート ・1−エチニル−2−メチル−2−ペンテニル シス/
トランス−クリサンテマート ・1−エチニル−2−メチル−2−ペンテニル 2,2
−ジメチル−3−(2−メチル−1−プロペニル)シク
ロプロパン−1−カルボキシレートD-2-methyl-4-oxo-3-propargylcyclopent-2-enyl d-cis / trans-chrysanthemate (generic name d, d-T80-praletrin: trade name Etok, Sumitomo Chemical Co., Ltd. Co., Ltd.) 2,3,5,6-tetrafluoro-4-methylbenzyl-3- (2'-chloro-3 ', 3', 3'-trifluoro-1-propenyl) -2,2- Dimethylcyclopropanecarboxylate (generic name tefluthrin) -2,3,5,6-tetrafluorobenzyl-3-
(2,2-Dichlorovinyl) -2,2-dimethylcyclopropanecarboxylate (generic name benfluthrin)-(S) -α-cyano-3-phenoxybenzyl (1
R, cis) -3- (2,2-dichlorovinyl) -2,2
-Dimethylcyclopropanecarboxylate- (R, S) -α-cyano-3-phenoxybenzyl
(1R, 1S) -cis / trans-3- (2,2-dichlorovinyl) -2,2-dimethylcyclopropanecarboxylate .alpha.-cyano-3-phenoxybenzyl d-cis / trans-chrysanthemate .1 -Ethynyl-2-methyl-2-pentenyl cis /
Trans-chrysanthemate 1-ethynyl-2-methyl-2-pentenyl 2,2
-Dimethyl-3- (2-methyl-1-propenyl) cyclopropane-1-carboxylate
【0017】・1−エチニル−2−メチル−2−ペンテ
ニル 2,2,3,3−テトラメチルシクロプロパンカ
ルボキシレート ・1−エチニル−2−メチル−2−ペンテニル 2,2
−ジメチル−3−(2,2−ジクロロビニル)シクロプ
ロパン−1−カルボキシレート ・O,O−ジメチル O−(2,2−ジクロロ)ビニル
ホスフェート ・O−イソプロポキシフェニル メチルカーバメート ・O,O−ジメチル O−(3−メチル−4−ニトロフ
ェニル)チオノフォスフェート ・O,O−ジエチル O−2−イソプロピル−4−メチ
ル−ピリミジル−(6)−チオフォスフェート ・O,O−ジメチル S−(1,2−ジカルボエトキシ
エチル)−ジチオフォスフェート なお、上記化合物には、その異性体も含まれる。1-ethynyl-2-methyl-2-pentenyl 2,2,3,3-tetramethylcyclopropanecarboxylate 1-ethynyl-2-methyl-2-pentenyl 2,2
-Dimethyl-3- (2,2-dichlorovinyl) cyclopropane-1-carboxylate-O, O-dimethyl O- (2,2-dichloro) vinyl phosphate-O-isopropoxyphenyl methylcarbamate-O, O- Dimethyl O- (3-methyl-4-nitrophenyl) thionophosphate * O, O-diethyl O-2-isopropyl-4-methyl-pyrimidyl- (6) -thiophosphate * O, O-dimethyl S- ( 1,2-Dicarboethoxyethyl) -dithiophosphate Note that the above compound also includes isomers thereof.
【0018】(消臭剤)(防臭剤) ラウリルメタクリレート、ゲラニルクロトネート、ミリ
スチル酸アセトフェノン、パラメチルアセトフェノンベ
ンズアルデヒド、酢酸ベンジル、プロピオン酸ベンジ
ル、アミルシンナミックアルデヒド、アニシックアルデ
ヒド、ジフェニルオキサイド、安息香酸メチル、安息香
酸エチル、フェニル酢酸メチル、フェニル酢酸エチル、
ネオリン、サフロール、セダウッド油、セダ菜油、シト
ロネラ油、ラバンテン油、ペテイグレイン油、レモング
ラス油等。(Deodorant) (Deodorant) Lauryl methacrylate, geranyl crotonate, acetophenone myristate, paramethylacetophenone benzaldehyde, benzyl acetate, benzyl propionate, amylcinnamic aldehyde, anisic aldehyde, diphenyl oxide, methyl benzoate , Ethyl benzoate, methyl phenylacetate, ethyl phenylacetate,
Neoline, safrole, seda wood oil, eda vegetable oil, citronella oil, Labanten oil, pete grain oil, lemongrass oil, etc.
【0019】(香 料)天然香料としては、じゃ香、霊
猫香、竜延香などの動物性香料;アビエス油、アジョク
ン油、アルモンド油、アンゲリカルート油、ページル
油、ペルガモット油、パーチ油、ボアバローズ油、カヤ
ブチ油、ガナンガ油、カプシカム、キャラウエー油、カ
ルダモン油、カシア油、セロリー油、シンナモン油、シ
トロネラ油、コニャック油、コリアンダー油、キュペブ
油、クミン油、樟脳油、ジル油、エストゴラン油、ユー
カリ油、フェンネル油、ガーリック油、ジンジャー油、
グレープフルーツ油、ホップ油、ジュニパーペリー油、
ローレルリーフ油、レモン油、レモングラス油、ロペー
ジ油、メース油、ナツメグ油、マンダリン油、タンゼリ
ン油、カラシ油、はつか油、燈花油、玉ねぎ油、こしょ
う油、オレンジ油、セイジ油、スターアニス油、テレピ
ン油、ウォームウッド油、ワニラ豆エキストラクトなど
の植物性香料を含む。(Fragrance) As natural fragrances, animal fragrances such as musk, spirit cat scent, longan scent, etc .; abies oil, ajokun oil, almond oil, angelica root oil, pagele oil, pergamot oil, perch oil, Boa Burroughs oil, Kayabuti oil, Gananga oil, Capsicum, Caraway oil, Cardamom oil, Cassia oil, Celery oil, Cinnamon oil, Citronella oil, Cognac oil, Coriander oil, Cuppeb oil, Cumin oil, Camphor oil, Zill oil, Estoran oil , Eucalyptus oil, fennel oil, garlic oil, ginger oil,
Grapefruit oil, hop oil, juniper perry oil,
Laurel leaf oil, lemon oil, lemongrass oil, ropage oil, mace oil, nutmeg oil, mandarin oil, tanzelin oil, mustard oil, hatsuka oil, lantern oil, onion oil, pepper oil, orange oil, sage oil, star anise Includes vegetable flavors such as oil, turpentine oil, warmwood oil, and vanilla bean extract.
【0020】人造香料は合成又は抽出香料であり、ピネ
ン、リモネンなどの炭化水素類;リナロール、ゲラニオ
ール、ジトロネロール、メントール、ボルネオール、ベ
ンジルアルコール、アニスアルコール、β−フェニルエ
チルアルコールなどのアルコール類;アネノール、オイ
ゲノールなどのフェノール類;n−ブチルアルデヒド、
イソブチルアルデヒド、ヘキシルアルデヒド、ヘプチル
アルデヒド、n−ノニルアルデヒド、ノナジエナール、
シトラール、シトロネラール、ベンズアルデヒド、シン
ナミックアルデヒド、ヘリオトロピン、ワニリンなどの
アルデヒド類;メチルアミルケトン、メチルノニルケト
ン、ジアセチル、アセチルプロピオニル、アセチルブチ
リル、カルボン、メントン、樟脳、アセトフェノン、p
−メチルアセトフェノン、イオノンなどのケトン類;ア
ミルブチロラクトン、メチルフェニルグリシド酸エチ
ル、γ−ノニルラクトン、クマリン、シネオールなどの
ラクトン又はオキシド類;メチルフォーメート、イソプ
ロピルフォーメート、リナリールフォーメート、エチル
アセテート、オクチルアセテート、メンチルアセテー
ト、ベンジルアセテート、シンナミルアセテート、プロ
ピオン酸ブチル、酢酸イソアミル、イソ酪酸イソプロピ
ル、イソ吉草酸グラニル、カプロン酸アリル、ヘプチル
酸ブチル、カプリル酸オクチル、ヘプチンカルボン酸メ
チル、ペラハゴン酸エチル、オクチンカルボン酸メチ
ル、カプリン酸イソアシル、ラウリン酸メチル、ミリス
チン酸エチル、安息香酸エチル、安息香酸ベンジル、フ
ェニル酢酸メチル、フェニル酢酸ブチル、桂皮酸メチ
ル、桂皮酸シンナミル、サルチル酸メチル、アニス酸エ
チル、アンスラニル酸メチル、エチルピルベート、エチ
ルα−ブチルブチレートなどのエステル類などを含む。
香料は一種類のみでもよいし、二種類以上を調合した調
合香料でもよい。香料とともに、パッチユリ油などの揮
発保留剤、オイゲノールなどの変調剤、その他香料工業
に使用される種々の成分を添加して差支えない。The artificial fragrance is a synthetic or extracted fragrance, and hydrocarbons such as pinene and limonene; alcohols such as linalool, geraniol, ditronellol, menthol, borneol, benzyl alcohol, anis alcohol and β-phenylethyl alcohol; Phenols such as eugenol; n-butyraldehyde,
Isobutyraldehyde, hexyl aldehyde, heptyl aldehyde, n-nonyl aldehyde, nonadienal,
Aldehydes such as citral, citronellal, benzaldehyde, cinnamic aldehyde, heliotropin, and vanillin; methylamyl ketone, methylnonyl ketone, diacetyl, acetylpropionyl, acetylbutyryl, carvone, menthone, camphor, acetophenone, p
-Ketones such as methylacetophenone and ionone; lactones and oxides such as amyl butyrolactone, ethyl methylphenylglycidate, γ-nonyl lactone, coumarin and cineol; methyl formate, isopropyl formate, linalyl formate, ethyl acetate , Octyl acetate, menthyl acetate, benzyl acetate, cinnamyl acetate, butyl propionate, isoamyl acetate, isopropyl isobutyrate, granyl isovalerate, allyl caproate, butyl heptylate, octyl caprylate, methyl heptine carboxylate, perahagonate Ethyl, methyl octylcarboxylate, isoacyl caprate, methyl laurate, ethyl myristate, ethyl benzoate, benzyl benzoate, methyl phenylacetate, fe Including Le butyl acetate, methyl cinnamate, cinnamyl cinnamate, methyl salicylate, ethyl anisate, methyl anthranilate, ethyl pyruvate, esters such as ethyl α- butyl butyrate and the like.
The fragrance may be only one kind, or a mixed fragrance prepared by mixing two or more kinds. Along with the fragrance, a volatilization retention agent such as patch lily oil, a modulator such as eugenol, and other various components used in the fragrance industry may be added.
【0021】(工業用殺菌剤) ・2,4,4′−トリクロロ−2′−ハイドロキシジフ
ェニル エーテル(イルガサンDP300、チバガイギ
ー社製)、 ・2,3,5,6−テトラクロロ−4(メチルスルフォ
ニル)ピリジン(ダウシルS−13、ダウケミカル社
製)、 ・アルキルベンジル ジメチルアンモニウム クロライ
ド(塩化ベンザルコニウム、日光ケミカルズ株式会社
製)、 ・ベンジルジメチル{2−[2−(p−1,1,3,3
−テトラメチル ブチルフェノキシ)エトキシ]エチ
ル}アンモニウム クロライド(塩化ベンゼトニウム、
三共株式会社製)、(Industrial bactericide) 2,4,4'-trichloro-2'-hydroxydiphenyl ether (Irgassan DP300, manufactured by Ciba Geigy), 2,3,5,6-tetrachloro-4 (methylsulfonyl) ) Pyridine (Dausil S-13, manufactured by Dow Chemical Co., Ltd.), alkylbenzyl dimethylammonium chloride (benzalkonium chloride, manufactured by Nikko Chemicals Co., Ltd.), benzyldimethyl {2- [2- (p-1,1,3) , 3
-Tetramethylbutylphenoxy) ethoxy] ethyl} ammonium chloride (benzethonium chloride,
Sankyo Co., Ltd.),
【0022】・4−イソプロピルトロポロン(ヒノキチ
オール、高砂香料工業株式会社製)、 ・N,N−ジメチル−N−フェニル−N′−(フルオロ
ジクロロメチルチオ)スルフォンアミド(プリベンドー
ルA4、バイエル社製)、 ・2−(4′−チアゾリル)ベンズイミダゾール(TB
Z、北興化学株式会社製)、 ・N−(フルオロジクロロメチルチオ)−フタ−ルイミ
ド(プリベントールA3 、バイエル社製)、 ・6−アセトキシ−2,4−ジメチル−m−ジオキシン
(ジオキシン、ジボーダン社製)等。4-isopropyl tropolone (hinokitiol, manufactured by Takasago International Corporation), N, N-dimethyl-N-phenyl-N '-(fluorodichloromethylthio) sulfonamide (prebendol A 4 , manufactured by Bayer) , 2- (4'-thiazolyl) benzimidazole (TB
Z, Hokko Chemical Co., Ltd.), - N-(fluorodichloromethylthio) - lid - Ruimido (Preventol toll A 3, manufactured by Bayer), - 6-acetoxy-2,4-dimethyl -m- dioxin (dioxin, Givaudan Manufactured by etc.)
【0023】(農業用殺菌剤) ・エチレンビス(ジチオカルバミド酸)亜鉛(ジネブ、
ロームアンドハース社製)、 ・エチレンビス(ジチオカルバミド酸)マンガン(マン
ネブ、ロームアンドハース社製)、 ・亜鉛、マンネブ錯化合物(マンゼブ、ロームアンドハ
ース社製)、 ・ビス(ジメチルジチオカルバミド酸)エチレンビス
(ジチオカルバミド酸)二亜鉛(ポリカーバメート、東
京有機化学社製)、 ・ビス(ジメチルチオカルバモイル)ジスルフィルド
(チラム、ロームアンドハース社製)、 ・クロトン酸 2,6−ジニトロ−4−オクチルフェニ
ル反応異性体混合物(DPC、ロームアンドハース社
製)、(Agricultural fungicide) -Zinc ethylenebis (dithiocarbamate) (Zineb,
Rohm and Haas), Manganese ethylenebis (dithiocarbamate) (Manneb, Rohm and Haas), Zinc, Manneb complex compound (Manzeb, Rohm and Haas), Bis (dimethyldithiocarbamic acid) Ethylene bis (dithiocarbamate) dizinc (polycarbamate, manufactured by Tokyo Organic Chemical Co., Ltd.), bis (dimethylthiocarbamoyl) disulfide (Thiram, manufactured by Rohm and Haas Co.), crotonic acid 2,6-dinitro-4-octyl Phenyl reaction isomer mixture (DPC, manufactured by Rohm and Haas),
【0024】・N−トリクロロメチルチオテトラヒドロ
フタルイミド(キャプタン、三共株式会社製)、 ・2,3−ジシアノ−1,4−ジチアアントラキノン
(ジチアノン、メルク社製)、 ・2,4−ジクロロ−6−(o−クロロアニリノ)−S
−トリアジン(トリアジン、富士化成薬株式会社製)、 ・S−n−ブチル S′−p−ターシャリ−ブチルベン
ジル N−3−ピリジルジオチカルボンイミデート(デ
ンマート、住友化学株式会社製)、N-trichloromethylthiotetrahydrophthalimide (Captan, Sankyo Co., Ltd.), 2,3-dicyano-1,4-dithiaanthraquinone (Dithianon, Merck Co.), 2,4-dichloro-6- (O-chloroanilino) -S
-Triazine (triazine, manufactured by Fuji Kasei Co., Ltd.), -Sn-butyl S'-p-tertiary-butylbenzyl N-3-pyridyldioticarbonimidate (Denmart, manufactured by Sumitomo Chemical Co., Ltd.),
【0025】・N−(3′,5′−ジクロロフェニル)
−1,2−ジメチルクロロプロパンジカルボキシイミド
(スミレックス)、 ・ビス(クロロフェニル)トリクロロエタノール(ケン
セン)、 ・6−メチルキノキサリン−2,3−ジチオカーボネー
ト(モレスタン)、 ・テトラクロロイソフタロニトリル(ダコニール)、 ・メチル−1−(ブチルカルバモイル)−2−ベンゾイ
ミダゾールカーバメート、プラストサイジンS−ベンジ
ルアミノベンゼンスルホネート、 ・ストレプトマイシン塩酸塩、 ・カスガマイシン塩酸塩、 ・シクロヘキシミド等.N- (3 ', 5'-dichlorophenyl)
-1,2-Dimethylchloropropanedicarboximide (Sumilex), bis (chlorophenyl) trichloroethanol (kensen), 6-methylquinoxaline-2,3-dithiocarbonate (morestan), tetrachloroisophthalonitrile (daconyl) ), Methyl-1- (butylcarbamoyl) -2-benzimidazole carbamate, plastocidin S-benzylaminobenzenesulfonate, streptomycin hydrochloride, kasugamycin hydrochloride, cycloheximide, etc.
【0026】(害虫忌避剤)ジメチルフタレート、2,
3,4,5−ビス(Δ2 −ブチレン)−テトラハイドロ
フラン、2,3,4,5−ビス−(Δ2 −ブチレン)−
テトラヒドロフルフリルアルコール、N,N−ジエチル
−m−トルアミド(DET)、カプリル酸ジエチルアミ
ド、2,3,4,5−ビス−(Δ2 −ブチレン)−テト
ラヒドロフルフラール、ジ−m−プロピル−イソシンコ
メロネート、第2級ブチルスチリルケトン、ノニルスチ
リルケトン、N−プロピルアセテトアニリド、2−エチ
ル−1,3−ヘキサンジオール、ジ−n−ブテルサクシ
ネート、2−ブトキシエチル−2−フルフリデンアセテ
ート、ジブチルフタレート、テトラヒドロチオフェン、
β−ナフトール、ジアリルジスルフィド、ビス(ジメチ
ルチオカルバモイル)ジスルフィド等。(Pest repellent) dimethyl phthalate, 2,
3,4,5-bis (delta 2 - butylene) - tetrahydrofuran, 2,3,4,5-bis - (delta 2 - butylene) -
Tetrahydrofurfuryl alcohol, N, N-diethyl-m-toluamide (DET), caprylic acid diethylamide, 2,3,4,5-bis- (Δ 2 -butylene) -tetrahydrofurfural, di-m-propyl-isocinco Melonate, secondary butyl styryl ketone, nonyl styryl ketone, N-propylacetetanilide, 2-ethyl-1,3-hexanediol, di-n-buter succinate, 2-butoxyethyl-2-furfuridene Acetate, dibutyl phthalate, tetrahydrothiophene,
β-naphthol, diallyl disulfide, bis (dimethylthiocarbamoyl) disulfide and the like.
【0027】(げつ歯類動物忌避剤)テトラメチルチウ
ラムジサルファイト、グアニジン、ナフタレンクレゾー
ル、シクロヘキシミド、ジンクジメチルジオカーバメイ
ト、シクロヘキシルアミン、N,N−ジメチルスルフェ
ニルジチオカルバメート等。 (犬ねこの忌避剤)2,6−ジメチル−オクタジエン−
(2,6)−al(8)(シトラール)、O,O−ジエ
チルS−2−エチルチオエチルジチオフォスフェート
(ETP)、O,O−ジメチルS−2−イソプロピルチ
オエチルジチオホスフェート(MIP)等。 (鳥類の忌避剤)r−クロラローゼ、4−(メチルチ
オ)−3,5−キシリル−N−メチルカーバメート、4
−アミノピリジンアンスラキノン、テトラメチルチウラ
ムジサルファイド、ジアリルジスルフィド等。(Rodent repellent) Tetramethylthiuram disulfite, guanidine, naphthalene cresol, cycloheximide, zinc dimethyl dicarbamate, cyclohexylamine, N, N-dimethylsulfenyldithiocarbamate and the like. (Repellent for dogs) 2,6-dimethyl-octadiene-
(2,6) -al (8) (citral), O, O-diethyl S-2-ethylthioethyldithiophosphate (ETP), O, O-dimethyl S-2-isopropylthioethyldithiophosphate (MIP) etc. (Avian repellent) r-chloralose, 4- (methylthio) -3,5-xylyl-N-methylcarbamate, 4
-Aminopyridine anthraquinone, tetramethylthiuram disulfide, diallyl disulfide and the like.
【0028】(げつ歯類動物駆除剤)アンツー、モノフ
ルオール酢酸ソーダ、ワルファリン、クマクロール、フ
マリン、クマテトラリルシリロシド、ノルボマイド、N
−3−ピリディルメチル−N′−ニトロフェニルウレ
ア、エンドロサイド、アルファナフチルチオ尿素、チオ
セミカルバジッド、デイフエナクム、ピバール、クロロ
ファシノン、シラトレン、カルシフェロール等。 (殺蟻剤)ペルメトリン、クロールデン等。 (防黴剤)α−ブロモ−シンナミックアルデヒド、N,
N−ジメチル−N−フェニル−N′−(フルオロジクロ
ロメチルチオ)−スルファミド等。 (植物生長調節剤)4−クロロフェノキシ酢酸、ジベレ
リン、N−(ジメチルアミノ)スクシンアミド、α−ナ
フチルアセトアミド等。 (除草剤)2,4−Dソーダ塩、3,4−ジクロロプロ
ピオンアニリド等。(Rodenticides) Antu, monofluorosodium acetate, warfarin, coumacral, fumarine, coumatetralyl silyloside, norbomide, N
-3-Pyridylmethyl-N'-nitrophenylurea, endroside, alphanaphthylthiourea, thiosemicarbazide, defenacum, pival, chlorofacinone, silatrene, calciferol and the like. (Anticide) Permethrin, Crawlden, etc. (Antifungal agent) α-bromo-cinnamic aldehyde, N,
N-dimethyl-N-phenyl-N '-(fluorodichloromethylthio) -sulfamide and the like. (Plant growth regulator) 4-chlorophenoxyacetic acid, gibberellin, N- (dimethylamino) succinamide, α-naphthylacetamide and the like. (Herbicides) 2,4-D soda salt, 3,4-dichloropropionanilide and the like.
【0029】上記薬剤は溶液形態に調製されることによ
り、本発明の水性薬剤が形成される。該薬剤溶液を調製
するための溶媒としては、前記した水性有機溶剤と水が
用いられ、また本発明の揮散性調整剤と水が用いられ
る。あるいはまた、本発明の揮散性調整剤と前記した水
性有機溶剤と水を混合して使用しても良い。前記薬剤は
一般に水に可溶性でないため、通常前記水性有機溶剤あ
るいは/および水性有機化合物に溶解してから、その薬
剤溶液を水と混合することにより調製される。その際、
薬剤が液中に安定して溶解状態が保持されるような後記
する添加剤を必要により添加するすることができる。水
性薬剤溶液を形成するのに用いる溶媒における水性有機
溶剤と水あるいは水性有機化合物と水、あるいはまた前
記した水性有機溶剤、水性有機化合物と水との配合割合
は、用いる水性有機溶剤や水性有機化合物の種類により
ことなるが、大体水性有機溶剤あるいは/および水性有
機化合物が30〜70%で、水が70〜30%である。
上記薬剤の溶液、すなわち本発明の加熱蒸散用水性薬剤
は、通常薬剤濃度が約0.2〜20重量%、好ましくは
0.5〜10重量%となるように調製される。The above-mentioned drug is prepared in the form of a solution to form the aqueous drug of the present invention. As the solvent for preparing the drug solution, the above-mentioned aqueous organic solvent and water are used, and the volatility adjusting agent of the present invention and water are used. Alternatively, the volatility adjusting agent of the present invention, the above-mentioned aqueous organic solvent and water may be mixed and used. Since the drug is generally not soluble in water, it is usually prepared by dissolving the drug in the aqueous organic solvent and / or the aqueous organic compound and then mixing the drug solution with water. that time,
If necessary, the below-mentioned additives may be added so that the drug can be stably dissolved in the liquid. The aqueous organic solvent and water or the aqueous organic compound and water in the solvent used to form the aqueous drug solution, or the above-mentioned aqueous organic solvent, the mixing ratio of the aqueous organic compound and water, the aqueous organic solvent and aqueous organic compound used Depending on the type, the water-based organic solvent or / and the water-based organic compound is about 30 to 70% and the water is about 70 to 30%.
The solution of the above-mentioned drug, that is, the aqueous drug for heat evaporation of the present invention is usually prepared so that the drug concentration is about 0.2 to 20% by weight, preferably 0.5 to 10% by weight.
【0030】本発明の加熱蒸散用水性薬剤には、前記の
水性有機溶剤や水性有機化合物と共に他の安定剤を併用
してもよい。そのような安定剤としては、従来加熱蒸散
用薬剤に使用されている各種安定剤を挙げることができ
る。例えば、安定剤として、揮散安定剤を使用する場合
には、先に出願した揮散安定剤として低級アルコールを
用いる技術を適用することができるが、その量は溶剤と
して用いている前記の水性有機溶剤や揮散性調整剤とし
て用いる水性有機化合物とは異なり、揮散の安定化のた
めに添加する関係上、前記の水性有機溶剤や水性有機化
合物よりもかなり少ない量でよい。その場合、この揮散
安定剤の水性薬剤に対する添加量は、添加すべき水性薬
剤の組成によっても異なる。In the aqueous agent for heat evaporation of the present invention, other stabilizers may be used in combination with the above-mentioned aqueous organic solvent or aqueous organic compound. Examples of such stabilizers include various stabilizers that have been conventionally used for chemicals for heat evaporation. For example, when using a volatilization stabilizer as a stabilizer, the technique of applying a lower alcohol as a volatilization stabilizer previously applied can be applied, but the amount thereof is the above-mentioned aqueous organic solvent used as a solvent. Unlike an aqueous organic compound used as a volatility adjusting agent or a volatility adjusting agent, it may be added in an amount considerably smaller than the above-mentioned aqueous organic solvent or aqueous organic compound because of the addition for stabilizing volatilization. In that case, the amount of the volatilization stabilizer added to the aqueous drug varies depending on the composition of the aqueous drug to be added.
【0031】また、この薬液(水性薬剤)を調製するさ
いには、薬剤の溶液の溶解性や加熱蒸散性を改善あるい
は調整するために次の化合物を添加してもよい。 ・3,5−ジ−t−ブチル−4−ヒドロキシトルエン
(以下BHTという) ・3−t−ブチル−4−ヒドロキシアニソール ・3,5−ジ−t−ブチル−4−ヒドロキシアニソール ・メルカプトベンズイミダゾール ・ジラウリル−チオ−ジ−プロピオネート ・2,2′−メチレン−ビス−(6−t−ブチル−4−
メチルフェノール) ・2,2′−メチレン−ビス−(6−t−ブチル−4−
エチルフェノール) ・4,4′−メチレン−ビス−(2,6−ジ−t−ブチ
ルフェノール) ・4,4′−ブチリデン−ビス−(6−t−ブチル−3
−メチルフェノール)When preparing this drug solution (aqueous drug), the following compounds may be added to improve or adjust the solubility of the drug solution and the heat evaporation property. * 3,5-di-t-butyl-4-hydroxytoluene (hereinafter referred to as BHT) * 3-t-butyl-4-hydroxyanisole * 3,5-di-t-butyl-4-hydroxyanisole * mercaptobenzimidazole Dilauryl-thio-di-propionate 2,2'-methylene-bis- (6-t-butyl-4-
Methylphenol) -2,2'-methylene-bis- (6-t-butyl-4-
Ethylphenol) 4,4'-methylene-bis- (2,6-di-t-butylphenol) 4,4'-butylidene-bis- (6-t-butyl-3)
-Methylphenol)
【0032】・4,4′−チオ−ビス−(6−t−ブチ
ル−3−メチルフェノール) ・1,1−ビス−(4−ヒドロキシフェニル)シクロヘ
キサン1,3,5−トリメチル−2,4,6−トリス
(3,5−ジ−t−ブチル−4−ヒドロキシベンジル)
ベンゼン ・トリス(2−メチル−4−ヒドロキシ−5−t−ブチ
ルフェニル)ブタン ・テトラキス[メチレン(3,5−ジ−t−ブチル−4
−ヒドロキシヒドロシンナメート)]メタン ・オクタデシル−3,5−ジ−t−ブチル−4−ヒドロ
キシヒドロシンナメート4,4'-thio-bis- (6-t-butyl-3-methylphenol) -1,1-bis- (4-hydroxyphenyl) cyclohexane 1,3,5-trimethyl-2,4 , 6-Tris (3,5-di-t-butyl-4-hydroxybenzyl)
Benzene-Tris (2-methyl-4-hydroxy-5-t-butylphenyl) butane-Tetrakis [methylene (3,5-di-t-butyl-4)
-Hydroxyhydrocinnamate)] methane octadecyl-3,5-di-t-butyl-4-hydroxyhydrocinnamate
【0033】・フェニル−β−ナフチルアミン ・N,N′−ジフェニル−p−フェニレンジアミン ・2,2,4−トリメチル−1,3−ジヒドロキノリン
ポリマー ・6−エトキシ−2,2,4−トリメチル−1,3−ジ
ヒドロキノリン ・2−t−ブチル−4−メトキシフェノール ・3−t−ブチル−4−メトキシフェノール ・2,6−ジ−t−ブチル−4−エチルフェノール ・ステアリル−β−(3,5−ジ−t−ブチル−4−ヒ
ドロキシフェニル)プロピオネート ・α−トコフェロール ・アスコルビン酸 ・エリソルビン酸Phenyl-β-naphthylamine N, N'-diphenyl-p-phenylenediamine 2,2,4-trimethyl-1,3-dihydroquinoline polymer 6-ethoxy-2,2,4-trimethyl- 1,3-dihydroquinoline, 2-t-butyl-4-methoxyphenol, 3-t-butyl-4-methoxyphenol, 2,6-di-t-butyl-4-ethylphenol, stearyl-β- (3 , 5-di-t-butyl-4-hydroxyphenyl) propionate-α-tocopherol-ascorbic acid-erythorbic acid
【0034】上記化合物はその1種を単独で用いてもよ
く、また2種以上併用することもできる。その使用量
は、本発明の水性薬剤中に約0.05〜10.0重量%
ないしはそれ以上、好ましくは0.1〜5.0重量%、
さらに好ましくは0.1〜2.0重量%含有される量と
するのが好ましい。本発明の加熱蒸散用水性薬剤及び本
発明の揮散性調整剤を配合した加熱蒸散用水性薬剤は、
従来公知の各種吸液芯を利用した吸上式加熱蒸散装置に
適用して、いずれも前記した所期の優れた効果を奏し得
る。そのような吸上式加熱蒸散装置としては、例えば特
公昭52−12106号公報、実開昭58−45670
号公報等に記載された装置である。The above compounds may be used alone or in combination of two or more. The amount used is about 0.05 to 10.0% by weight in the aqueous medicine of the present invention.
Or more, preferably 0.1 to 5.0% by weight,
More preferably, the amount is 0.1 to 2.0% by weight. The heat-evaporating aqueous agent of the present invention and the heat-evaporating aqueous agent containing the volatility adjusting agent of the present invention are
The present invention can be applied to a wicking type heating evaporation device using various conventionally known liquid-wicking cores, and any of them can achieve the above-mentioned desired excellent effects. As such a wicking type heating evaporation device, for example, Japanese Examined Patent Publication No. 52-12106 and Japanese Utility Model Laid-Open No. 58-45670.
This is the device described in Japanese Patent Publication No.
【0035】上記装置に利用される吸液芯(1)として
は、通常用いられている各種素材、例えばフエルト、木
綿、パルプ、不織布、石綿、無機質成型物等のいずれか
らなるものでもよいが、中でもフエルト芯、素焼芯、パ
ルプ芯及び無機質成型芯が好ましい。上記無機質成型芯
の具体例としては磁器多孔質、グラスファイバー、石綿
等の無機繊維を石膏やベントナイト等の結合剤で固めた
ものや、カオリン、活性白土、タルク、ケイソウ土、ク
レー、パーライト、ベントナイト、アルミナ、シリカ、
アルミナシリカ、チタニア、ガラス質火山岩焼成粉末、
ガラス質火山灰焼成粉末等の鉱物質粉末を、単独で又は
木粉、炭粉、活性炭等と共に結合剤、例えばポバールを
熱処理(150℃程度の温度で数分加熱)したもの、ポ
バールにメラミン樹脂や重クロム酸アンモニウムのよう
な耐水化剤を1〜10%程度添加したもの、或いは架橋
型でんぷん、これとα−でんぷんとの混合物、α−グル
テンとカプロラクトンとの混合物のような耐水性結合剤
で固めたものを例示できる。結合剤として合成樹脂系の
ものも使用できるが、水系薬液を吸液する関係で前記の
ような親水性結合剤を耐水性にしたものが好ましい。特
に好ましい吸液芯は、上記鉱物質粉末100重量部と木
粉又は該木粉等重量までの炭粉及び/又は活性炭を混合
した混合物10〜300重量部とに前記耐水性結合剤を
全吸液芯重量の5〜25重量%となるまで配合し、更に
これらに水を加えて練合押出し成型後、焼成することに
より製造される。このような成形焼成芯やブラスチック
多孔質芯の吸水率は15〜50%のものがよく、特に2
0〜40%のものが好ましい。The liquid absorbent core (1) used in the above apparatus may be made of any of various commonly used materials such as felt, cotton, pulp, non-woven fabric, asbestos and inorganic moldings. Of these, a felt core, an unfired core, a pulp core and an inorganic molded core are preferable. Specific examples of the inorganic molding core include porcelain porous material, glass fiber, inorganic fiber such as asbestos hardened with a binder such as gypsum or bentonite, kaolin, activated clay, talc, diatomaceous earth, clay, perlite, bentonite. , Alumina, silica,
Alumina-silica, titania, glassy volcanic rock firing powder,
Mineral powder such as glassy volcanic ash fired powder, alone or with wood powder, charcoal powder, activated carbon, etc., as a binder, such as heat-treated Povar (heated at a temperature of about 150 ° C for several minutes), Povar with melamine resin or A water resistant binder such as ammonium dichromate to which a water resistant agent is added in an amount of about 1 to 10%, or crosslinked starch, a mixture of this and α-starch, or a mixture of α-gluten and caprolactone. A solidified product can be exemplified. Although a synthetic resin-based binder can also be used as the binder, it is preferable that the hydrophilic binder as described above is made water resistant in order to absorb the aqueous chemical solution. A particularly preferable liquid absorbent core absorbs 100 parts by weight of the above-mentioned mineral powder and 10 to 300 parts by weight of a mixture of wood powder or carbon powder and / or activated carbon up to the same weight as the wood powder, all of the water-resistant binder. It is produced by blending the mixture until it reaches 5 to 25% by weight of the weight of the liquid core, further adding water to these, kneading and extruding, and then firing. The water absorption of the molded fired core or the plastic porous core is preferably 15 to 50%, particularly 2
It is preferably 0 to 40%.
【0036】該吸液芯は、吸液速度が0.1〜15時
間、好ましくは0.2〜3時間であるのが望ましい。こ
の吸液速度とは、液温25℃の液中に直径7mm×長さ
70mmの吸液芯をその下部より15mmまで浸漬し、
芯頂に水又は水/BDG(60/40)が達するまでの
時間を測定することにより求められた値を意味する。ま
た上記吸液芯中には、上記鉱物質粉末、木粉及び糊剤の
他更に必要に応じてマラカイトグリーン等の色素、ソル
ビン酸及びその塩類、デヒドロ酢酸等のカビ止め剤等を
配合することもできる。The liquid absorbent core has a liquid absorption rate of 0.1 to 15 hours, preferably 0.2 to 3 hours. The liquid absorption rate means that a liquid absorption core having a diameter of 7 mm and a length of 70 mm is immersed in a liquid having a liquid temperature of 25 ° C. from its lower portion to 15 mm,
It means a value obtained by measuring the time required for water or water / BDG (60/40) to reach the core apex. Further, in the liquid absorbent core, in addition to the above mineral powder, wood flour and sizing agent, if necessary, a pigment such as malachite green, sorbic acid and salts thereof, and a fungicide such as dehydroacetic acid, etc. You can also
【0037】また、吸液芯(1)の別の実施可能な形態
として、吸液芯の中心に多孔質の吸液蒸散層を有し、周
囲に保持材層を有する構造の吸液芯が例示できる。多孔
質の吸液蒸散層としては、前記吸液芯として例示したフ
ェルト、木綿、パルプ、不織布、石綿、無機質成型物に
加えポリエステルなどの合成繊維、吸水性の高い木材が
好適である。そして周囲の保持材層としては、チューブ
状の力学的に十分な強度を有し、本組成物に対して及び
熱に対して十分な耐性を有するものから選択される材
料、例えば、ポリエステル、ナイロン等の合成繊維、無
機繊維、ポリエチレン、ポリプロピレン、ポリ塩化ビニ
ル、ポリアクリル、フェノール樹脂などのプラスチッ
ク、銅、真鍮、鉄、ステンレス鋼、アルミニウムなどの
金属、陶磁器、ガラス等から構成される。そして、フェ
ルト、木綿、パルプ、不織布、石綿、無機質成型物など
にリン酸バリウムを付着させることで、その薬剤吸上げ
性能が長時間安定に維持することができる。また上記装
置に利用される発熱体としては、通常通電により発熱す
る発熱体が汎用されているが、使用する発熱体の種類は
特に限定されない。その発熱体において保持される温度
は、通常約40〜450℃、好ましくは70〜150
℃、より好ましくは85〜145℃の範囲の発熱体表面
温度とされ、これは吸液芯表面温度約30〜440℃、
好ましくは約60〜145℃、より好ましくは約70〜
143℃に相当する。As another possible embodiment of the liquid absorbent core (1), there is provided a liquid absorbent core having a structure having a porous liquid absorbent evaporation layer in the center of the liquid absorbent core and a holding material layer in the periphery. It can be illustrated. As the porous liquid absorbing / evaporating layer, felt, cotton, pulp, non-woven fabric, asbestos, inorganic molded products, synthetic fibers such as polyester, and wood having high water absorbing property are suitable as the liquid absorbing core. And as the surrounding holding material layer, a material selected from those having a tube-like mechanically sufficient strength and having sufficient resistance to the present composition and to heat, for example, polyester, nylon And the like, synthetic fibers such as, inorganic fibers, plastics such as polyethylene, polypropylene, polyvinyl chloride, polyacryl and phenol resin, metals such as copper, brass, iron, stainless steel and aluminum, ceramics, glass and the like. By adhering barium phosphate to felt, cotton, pulp, non-woven fabric, asbestos, inorganic molding, etc., the chemical absorption performance can be maintained stably for a long time. As the heating element used in the above-mentioned device, a heating element that normally generates heat when energized is generally used, but the type of heating element used is not particularly limited. The temperature maintained in the heating element is usually about 40 to 450 ° C, preferably 70 to 150 ° C.
C., more preferably 85 to 145.degree. C. in the range of the heating element surface temperature, which is about 30 to 440.degree.
Preferably about 60-145 ° C, more preferably about 70-
Corresponds to 143 ° C.
【0038】[0038]
【作用】本発明では、薬液に水を含有する水性薬剤にお
いて、溶媒として分子量が75〜170の水性有機溶剤
を用いて加熱蒸散用水性薬剤を構成すること、あるいは
/及び前記の水性有機化合物を用いた水性薬剤の揮散性
調整剤を配合して加熱蒸散用水性薬剤を構成することに
より、極めて優れた有効揮散率が得られると共に、吸液
芯の目詰まりもなく有効成分に応じた持続的な効果を発
揮することができる。特に揮散性調整剤を配合した加熱
蒸散用水性薬剤は、加熱蒸散の期間中蒸散する有効薬剤
の量が一定し、かつ長期間にわたり吸液芯の目詰まりも
なく、蒸散の終期においても溶液の組成が変化し、薬剤
の可溶化が不可能となり、白濁を示すことがないという
優れた性能を発揮することができる。本発明では、溶媒
として分子量が75〜170の水性有機溶剤を用い、あ
るいは/及び前記の水性有機化合物を用いていることに
より前記の効果を奏するが、それによる作用機構は明確
ではない。本発明では、比較的高分子量の水性有機溶剤
や水性有機化合物を使用しないため、芯中での薬剤の残
存がなく、有効成分の揮散を均一にすることが可能とな
った。また、水溶液のため周囲温度上昇によるボトル内
圧上昇が抑制され、液もれを防止することが可能であ
る。さらに、本発明の水性薬剤では、水の量を60%以
上とすることにより、危険物の対象外となり、使用に際
して極めて安全である。また、本発明では、溶媒として
使用する分子量が75〜170の水性有機溶剤及び前記
の水性有機化合物は、薬剤及び水を溶解するものであ
り、かつこれらの溶剤は沸点が大体約100〜300℃
の範囲にあって、前記の効果を奏する原因となっている
ものとみられる。In the present invention, in an aqueous drug containing water in a drug solution, the aqueous drug for heat evaporation is constituted by using an aqueous organic solvent having a molecular weight of 75 to 170 as a solvent, and / or the above aqueous organic compound is added. By combining the volatility adjusting agent of the aqueous drug used to form the aqueous drug for heat evaporation, an extremely excellent effective volatilization rate is obtained, and there is no clogging of the liquid absorbent core and continuous treatment depending on the active ingredient. It is possible to exert a great effect. In particular, the aqueous agent for heating evaporation containing a volatility adjusting agent has a constant amount of the effective agent that evaporates during the heating evaporation, and the clogging of the absorbent core does not occur for a long period of time, and the solution remains in solution even at the end of evaporation. It is possible to exhibit excellent performance that the composition is changed, solubilization of the drug becomes impossible, and white turbidity does not occur. In the present invention, the above effect is exhibited by using an aqueous organic solvent having a molecular weight of 75 to 170 as a solvent and / or using the above aqueous organic compound, but the mechanism of action by it is not clear. In the present invention, since a relatively high molecular weight aqueous organic solvent or aqueous organic compound is not used, there is no drug remaining in the core, and it is possible to evenly vaporize the active ingredient. Further, since the solution is an aqueous solution, an increase in internal pressure of the bottle due to an increase in ambient temperature is suppressed, and it is possible to prevent liquid leakage. Furthermore, in the case of the aqueous medicine of the present invention, when the amount of water is 60% or more, it is excluded from the object of dangerous substances and is extremely safe in use. Further, in the present invention, the aqueous organic solvent having a molecular weight of 75 to 170 used as a solvent and the above-mentioned aqueous organic compound dissolve the drug and water, and these solvents have a boiling point of about 100 to 300 ° C.
It is considered that it is the cause of the above effects in the range of.
【0039】[0039]
【実施例】以下、実施例により本発明を具体的に説明す
る。ただし、本発明は、これらの実施例のみに限定され
るものではない。 実施例1〜7 加熱蒸散用薬剤の有効成分としてd,d−T80プラレ
トリン(商品名エトック)0.6wt%を含有するよう
に、この加熱蒸散用薬剤とともに、各種水性有機溶剤、
水、その他の添加剤を、第1表に示す割合で混合して加
熱蒸散用水性薬剤を調製した。第1表に示すA、B、
F、H、I、J及びKの各種水性有機溶剤の具体的種類
は第2表及び第3表に示す。また、第2表及び第3表に
は、AからLまで、及びアの各種水性有機溶剤の具体的
種類が示してある。なお、(水性有機溶剤+水)の量は
加熱蒸散性薬剤とその他の添加剤との合計量を除いた残
りの量である。また、添加剤のBHTは従来揮散性調整
剤として添加されているものであるが、通常の添加剤と
異なるので、それと区別するために、ここでは添加剤と
別にした。 比較例8〜10 本発明の水性有機溶剤を添加混合しない外は、実施例1
〜7と同様にして加熱蒸散用水性薬剤を調製した。使用
した薬剤等の内容は第1表に示す。EXAMPLES The present invention will be specifically described below with reference to examples. However, the present invention is not limited to these examples. Examples 1 to 7 In order to contain 0.6 wt% of d, d-T80 pralethrin (trade name Etoc) as an active ingredient of the agent for heat evaporation, various aqueous organic solvents were added together with the agent for heat evaporation.
Water and other additives were mixed in the proportions shown in Table 1 to prepare an aqueous medicine for heat evaporation. A, B shown in Table 1,
Specific types of various aqueous organic solvents of F, H, I, J and K are shown in Tables 2 and 3. Further, Tables 2 and 3 show the specific types of various aqueous organic solvents from A to L and a. The amount of (aqueous organic solvent + water) is the remaining amount excluding the total amount of the heat vaporizable chemical and other additives. Further, BHT as an additive is conventionally added as a volatility adjusting agent, but since it is different from a normal additive, it is separated from the additive here in order to distinguish it from it. Comparative Examples 8 to 10 Example 1 except that the aqueous organic solvent of the present invention was not added and mixed.
An aqueous drug for heat evaporation was prepared in the same manner as described above. Table 1 shows the contents of the medicines used.
【0040】[0040]
【表1】 [Table 1]
【0041】[0041]
【表2】 [Table 2]
【0042】[0042]
【表3】 [Table 3]
【0043】なお、第1表において、PP:ポリプロピ
レン。上記実施例1〜7で調製した本発明の水性有機溶
剤を含有する水性薬剤の試料、及び比較例8〜10で得
た薬液の試料(比較試料)の夫々50mlを、第1図に
示す容器(3)に入れ、発熱体(4)に通電して吸液芯
(1)の上側面部を温度130℃に加熱し、該加熱によ
る試料中の薬剤の蒸散試験を行なった。吸液芯(1)と
しては第1表に示す材質のもので、直径7mmのものを
用い、また発熱体(4)はリングヒーターを用いた。薬
剤の揮散量は、揮散蒸気を毎時間毎にシリカゲルカラム
に吸引捕集し、このシリカゲルをアセトンで抽出し、濃
縮後ガスクロマトグラフにて定量分析した。試料の加熱
開始より第1日後、第15日後、及び第30日後の1日
に12時間通電した場合の薬剤揮散量mg/12hrを
求めた結果、並びに360時間後の液の外観状態の変化
を下記第4表に示す。In Table 1, PP: polypropylene. A container shown in FIG. 1 is provided with 50 ml each of a sample of an aqueous drug containing the aqueous organic solvent of the present invention prepared in the above Examples 1 to 7 and a sample of a liquid medicine (comparative sample) obtained in Comparative Examples 8 to 10. It was placed in (3) and the heating element (4) was energized to heat the upper side surface of the liquid absorbent core (1) to a temperature of 130 ° C., and a transpiration test of the drug in the sample by the heating was conducted. The absorbent core (1) was made of the material shown in Table 1 and had a diameter of 7 mm, and the heating element (4) was a ring heater. For the amount of the chemical vaporized, the vaporized vapor was suctioned and collected on a silica gel column every hour, the silica gel was extracted with acetone, and after concentration, quantitative analysis was carried out by a gas chromatograph. The results of obtaining the drug volatilization amount mg / 12 hr when electricity was applied for 12 hours on the 1st day, 15th day, and 30th day from the start of heating the sample, and the change in the appearance state of the liquid after 360 hours The results are shown in Table 4 below.
【0044】[0044]
【表4】 [Table 4]
【0045】上記第4表によれば、本発明の水性有機溶
剤を用いる実施例1〜7の場合にはいずれも薬剤揮散量
が日数の経過によらず低下することがなく、むしろ第1
5日では当初よりも増加しており、その状態は第30日
でも同様であって、薬剤の揮散が安定して行われてい
る。また、液の外観状態は透明で当初の状態とあまり変
化は認められなかった。これに対して、比較例8〜10
の場合にはいずれも第30日では当初に比して薬剤揮散
量が低下しており、また360時間経過後の外観は、白
濁、分離を生じており、これらの結果から、本発明にお
いては、薬剤の加熱蒸散を安定して、かつ高く維持して
行うことができることが明白である。According to Table 4 above, in any of Examples 1 to 7 in which the aqueous organic solvent of the present invention was used, the amount of drug volatilization did not decrease with the passage of days, but rather the first
It increased from the beginning on the 5th day, and the state was the same on the 30th day, and the volatilization of the drug was stably performed. In addition, the appearance of the liquid was transparent and did not change much from the initial state. On the other hand, Comparative Examples 8 to 10
In all cases, the amount of drug volatilization was lower than that at the beginning on the 30th day, and the appearance after 360 hours had white turbidity and separation. From these results, in the present invention, It is obvious that the heat transpiration of the drug can be carried out stably and at a high level.
【0046】実施例11〜16 加熱蒸散用薬剤の有効成分としてd,d−T80プラレ
トリン(商品名エトック)0.6wt%を含有するよう
に、この加熱蒸散用薬剤とともに、各種水性有機溶剤、
水、その他の添加剤を、第5表に示す割合で混合して加
熱蒸散用水性薬剤を調製した。第5表に示すM〜Rの各
種水性有機溶剤の具体的種類は第6表に示す。なお、
(水性有機溶剤+水)の量は加熱蒸散性薬剤とその他の
添加剤との合計量を除いた残りの量である。また、添加
剤のBHTは従来揮散性調整剤として添加されているも
のであるが、通常の添加剤と異なるので、それと区別す
るために、ここでは添加剤と別にした。Examples 11 to 16 To contain 0.6 wt% of d, d-T80 pralethrin (trade name Etoc) as an active ingredient of the agent for heat evaporation, various aqueous organic solvents were added together with the agent for heat evaporation.
Water and other additives were mixed in the proportions shown in Table 5 to prepare an aqueous medicine for heat evaporation. Table 6 shows specific types of various aqueous organic solvents M to R shown in Table 5. In addition,
The amount of (aqueous organic solvent + water) is the remaining amount excluding the total amount of the heat evaporative agent and other additives. Further, BHT as an additive is conventionally added as a volatility adjusting agent, but since it is different from a normal additive, it is separated from the additive here in order to distinguish it from it.
【0047】[0047]
【表5】 [Table 5]
【0048】[0048]
【表6】 [Table 6]
【0049】上記実施例11〜16で調製した本発明の
水性有機溶剤を含有する水性薬剤の試料の夫々50ml
を、第1図に示す容器(3)に入れ、発熱体(4)に通
電して吸液芯(1)の上側面部を温度130℃に加熱
し、該加熱による試料中の薬剤の蒸散試験を行なった。
吸液芯(1)としては第5表に示す材質のもので、直径
7mmのものを用い、また発熱体(4)はリングヒータ
ーを用いた。薬剤の揮散量は、揮散蒸気を毎時間毎にシ
リカゲルカラムに吸引捕集し、このシリカゲルをアセト
ンで抽出し、濃縮後ガスクロマトグラフにて定量分析し
た。試料の加熱開始より第1日後、第15日後、及び第
30日後の1日に12時間通電した場合の薬剤揮散量m
g/12hrを求めた結果を下記第7表に示す。50 ml of each of the aqueous drug samples containing the aqueous organic solvent of the present invention prepared in the above Examples 11 to 16
In a container (3) shown in FIG. 1 and energizing a heating element (4) to heat the upper side surface of the liquid absorbent core (1) to a temperature of 130 ° C., and evaporation of the drug in the sample by the heating. The test was conducted.
The absorbent core (1) was made of the material shown in Table 5 and had a diameter of 7 mm, and the heating element (4) was a ring heater. For the amount of the chemical vaporized, the vaporized vapor was suctioned and collected on a silica gel column every hour, the silica gel was extracted with acetone, and after concentration, quantitative analysis was carried out by a gas chromatograph. Amount of chemical vaporization m when electricity is supplied for 12 hours on the 1st day, 15th day, and 30th day after the start of heating of the sample
The results of determining g / 12 hr are shown in Table 7 below.
【0050】[0050]
【表7】 [Table 7]
【0051】上記第7表によれば、本発明の水性有機溶
剤を用いる時には、薬剤揮散量が日数の経過によらず低
下することがなく、むしろ第15日では当初よりも増加
しており、その状態は第30日でも同様であって、薬剤
の揮散が安定して行われていることがわかる。According to Table 7 above, when the aqueous organic solvent of the present invention is used, the amount of drug volatilization does not decrease regardless of the number of days, but rather increases on the 15th day from the beginning. The state is the same on the 30th day, and it can be seen that the volatilization of the drug is performed stably.
【0052】実施例17〜26 加熱蒸散用薬剤の有効成分としてd,d−T80プラレ
トリン(商品名エトック)0.6wt%を含有するよう
に、この加熱蒸散用水性薬剤とともに、各種の前記水性
有機化合物、水、その他の添加剤を、第8表に示す割合
で混合して加熱蒸散用水性薬剤を調製した。第8表に示
すS〜Zの各種水性有機化合物の具体的種類は第9表及
び第10表に示す。なお、(水性有機化合物+水)の量
は加熱蒸散性薬剤とその他の添加剤との合計量を除いた
残りの量である。 比較例27 本発明の有機溶媒や水性有機化合物を添加混合しない外
は、実施例17〜26と同様にして加熱蒸散用水性薬剤
を調製した。使用した薬剤等の内容は第8表に示す。Examples 17 to 26 The heat-evaporative drug contains 0.6 wt% of d, d-T80 pralethrin (trade name Etoc) as an active ingredient of the heat-evaporative drug. The compound, water, and other additives were mixed in the proportions shown in Table 8 to prepare an aqueous drug for heat evaporation. Specific types of various aqueous organic compounds S to Z shown in Table 8 are shown in Tables 9 and 10. In addition, the amount of (aqueous organic compound + water) is the remaining amount excluding the total amount of the heat vaporizable chemical and other additives. Comparative Example 27 An aqueous drug for heat evaporation was prepared in the same manner as in Examples 17 to 26, except that the organic solvent or aqueous organic compound of the present invention was not added and mixed. Table 8 shows the contents of the medicines used.
【0053】[0053]
【表8】 [Table 8]
【0054】[0054]
【表9】 [Table 9]
【0055】[0055]
【表10】 [Table 10]
【0056】上記実施例17〜26で調製した本発明の
水性有機有機化合物を含有する水性薬剤の試料、及び比
較例27で得た薬液の試料(比較試料)の夫々50ml
を、第1図に示す容器(3)に入れ、発熱体(4)に通
電して吸液芯(1)の上側面部を温度130℃に加熱
し、該加熱による試料中の薬剤の蒸散試験を行なった。
吸液芯(1)としては第8表に示す材質のもので、直径
6mmのものを用い、また発熱体(4)はリングヒータ
ーを用いた。薬剤の揮散量は、揮散蒸気を毎時間毎にシ
リカゲルカラムに吸引捕集し、このシリカゲルをアセト
ンで抽出し、濃縮後ガスクロマトグラフにて定量分析し
た。試料の加熱開始より第5時間後、第100時間後、
第200時間後及び第300時間後の1時間当りの薬剤
揮散量mg/hrを求めた結果を下記第11表に示す。50 ml each of the sample of the aqueous drug containing the aqueous organic-organic compound of the present invention prepared in Examples 17 to 26 and the sample of the drug solution obtained in Comparative Example 27 (comparative sample)
In a container (3) shown in FIG. 1 and energizing a heating element (4) to heat the upper side surface of the liquid absorbent core (1) to a temperature of 130 ° C., and evaporation of the drug in the sample by the heating. The test was conducted.
The liquid absorbent core (1) was made of the material shown in Table 8 and had a diameter of 6 mm, and the heating element (4) was a ring heater. For the amount of the chemical vaporized, the vaporized vapor was suctioned and collected on a silica gel column every hour, the silica gel was extracted with acetone, and after concentration, quantitative analysis was carried out by a gas chromatograph. After 5 hours and 100 hours from the start of heating the sample,
The results of obtaining the drug volatilization amount mg / hr per hour after the 200th hour and the 300th hour are shown in Table 11 below.
【0057】[0057]
【表11】 [Table 11]
【0058】上記第11表によれば、本発明の水性有機
化合物を用いる時には、薬剤揮散量が日数の経過によら
ず低下することがなく、むしろ第200時間後では当初
よりも増加しており、その状態は第300時間後でも同
様であって、薬剤の揮散が安定して行われていることが
わかる。本発明の加熱蒸散用水性薬剤の揮散性調整剤を
添加した場合においては、比較例でn−パラフィンを添
加した場合と同様に薬剤の加熱蒸散を安定して、かつ高
く維持して行うことができることが明白である。According to Table 11 above, when the aqueous organic compound of the present invention is used, the drug volatilization amount does not decrease regardless of the number of days elapsed, but rather increases after 200 hours from the beginning. The state is the same after the 300th hour, and it can be seen that the drug is stably vaporized. In the case of adding the volatility adjusting agent of the aqueous drug for heat evaporation of the present invention, the heat evaporation of the drug can be performed stably and at a high level as in the case of adding n-paraffin in Comparative Example. It is clear that you can do it.
【0059】実施例28〜32 実施例28〜30には、加熱蒸散用薬剤の有効成分とし
てd,d−T80プラレトリン(商品名エトック)0.
6wt%を含有するように、また実施例31にはエスビ
オールを0.6wt%含有するように、さらにまた実施
例32にはd,d−T80プラレトリン(商品名エトッ
ク)0.6wt%を含有するように、しかしてこれらの
加熱蒸散用水性薬剤とともに、各種の前記水性有機化合
物、前記水性有機溶剤、水、その他の添加剤を、第12
表に示す割合で混合して加熱蒸散用水性薬剤を調製し
た。第12表に示す水性有機化合物及び有機溶剤の中実
施例28〜31に使用のものの具体的種類はすでに第2
表に(Bとして)また10表に(Zとして)示してあ
る。実施例32に使用の水性有機化合物の具体的種類は
10表に(イとして)示してある。なお、(水性有機化
合物+水)の量は加熱蒸散性薬剤とその他の添加剤との
合計量を除いた残りの量である。Examples 28 to 32 In Examples 28 to 30, d, d-T80 pralethrin (trade name: Etoc) as an active ingredient of a drug for heat evaporation was used.
6 wt%, Example 31 contains 0.6 wt% of esbiol, and Example 32 contains 0.6 wt% of d, d-T80 pralethrin (trade name Etok). Thus, together with these aqueous agents for heat vaporization, various aqueous organic compounds, aqueous organic solvents, water, and other additives are
An aqueous drug for heat vaporization was prepared by mixing at the ratios shown in the table. Among the aqueous organic compounds and organic solvents shown in Table 12, the specific types of those used in Examples 28 to 31 are already the second one.
It is shown in the table (as B) and in table 10 (as Z). Specific types of aqueous organic compounds used in Example 32 are shown in Table 10 (as a). In addition, the amount of (aqueous organic compound + water) is the remaining amount excluding the total amount of the heat vaporizable chemical and other additives.
【0060】[0060]
【表12】 [Table 12]
【0061】上記実施例27〜32で調製した本発明の
水性有機有機化合物あるいは水性有機有機溶剤を含有す
る水性薬剤の試料で得た薬液の試料の夫々50mlを、
第1図に示す容器(3)に入れ、発熱体(4)に通電し
て吸液芯(1)の上側面部を温度130℃に加熱し、該
加熱による試料中の薬剤の蒸散試験を行なった。吸液芯
(1)としては第12表に示す材質のもので、直径6m
mのものを用い、また発熱体(4)はリングヒーターを
用いた。薬剤の揮散量は、揮散蒸気を毎時間毎にシリカ
ゲルカラムに吸引捕集し、このシリカゲルをアセトンで
抽出し、濃縮後ガスクロマトグラフにて定量分析した。50 ml of each of the samples of the liquid chemicals obtained from the samples of the aqueous medicine containing the aqueous organic-organic compound or the aqueous organic-organic solvent of the present invention prepared in Examples 27 to 32 above,
In a container (3) shown in FIG. 1, the heating element (4) is energized to heat the upper side surface of the liquid absorbent core (1) to a temperature of 130 ° C., and a transpiration test of the drug in the sample is carried out by the heating. I did. The absorbent core (1) is made of the material shown in Table 12 and has a diameter of 6 m.
m, and the heating element (4) was a ring heater. For the amount of the chemical vaporized, the vaporized vapor was suctioned and collected on a silica gel column every hour, the silica gel was extracted with acetone, and after concentration, quantitative analysis was carried out by a gas chromatograph.
【0062】実施例27〜31で調製した本発明の試料
の加熱開始より第5時間後、第100時間後、第200
時間後及び第300時間後の1時間当りの薬剤揮散量m
g/hrを求めた結果を下記第13表に示す。また、実
施例32で調製した本発明の試料の加熱開始より第1日
後、第15日後、及び第30日後の1日に12時間通電
した場合の薬剤揮散量mg/12hrを求めた結果を下
記第14表に示す。Fifth, 100th and 200th hours after the start of heating the samples of the present invention prepared in Examples 27 to 31.
Amount of chemical vaporization per hour after hour and after 300 hours m
The results of g / hr are shown in Table 13 below. Further, the results of obtaining the drug volatilization amount mg / 12 hr when the sample of the present invention prepared in Example 32 was energized for 12 hours on the first day, the fifteenth day, and the thirtieth day from the start of heating, are shown below. It is shown in Table 14.
【0063】[0063]
【表13】 [Table 13]
【0064】[0064]
【表14】 [Table 14]
【0065】上記第13表および第14表によれば、本
発明の水性有機化合物、水性有機溶剤を用いる時には、
水性有機化合物、水性有機溶剤の使用量が8重量%程度
の少量であっても、薬剤揮散量が日数の経過によらず低
下することがなく、薬剤の揮散が安定して行われている
ことがわかる。According to Tables 13 and 14 above, when the aqueous organic compound and the aqueous organic solvent of the present invention are used,
Even if the amount of the aqueous organic compound or the aqueous organic solvent used is as small as about 8% by weight, the amount of the drug volatilized does not decrease regardless of the number of days and the drug is volatilized stably. I understand.
【0066】[0066]
【発明の効果】本発明によれば、特定の水性有機溶剤を
用いて加熱蒸散用水性薬剤を構成することにより、薬剤
の加熱蒸散に際して、薬剤の揮散が一定して行われ、吸
液芯を用いる加熱蒸散において吸液芯の目詰まりが殆ど
なく、安定した加熱蒸散がなされる。また特定の水性有
機化合物を用いて加熱蒸散用水性薬剤の揮散調整剤を構
成し、調整した揮散調整剤を用いて加熱蒸散用水性薬剤
を構成することにより、薬剤の加熱蒸散に際して、薬剤
の揮散が一定して行われ、吸液芯を用いる加熱蒸散にお
いて吸液芯の目詰まりが殆どなく、長期間に亘たり均一
に薬剤の加熱蒸散が行われ、通電後期においても加熱蒸
散用水性薬剤の組成に変化がなく、液に白濁が生じな
い。EFFECTS OF THE INVENTION According to the present invention, by constructing an aqueous medicine for heat evaporation by using a specific aqueous organic solvent, the evaporation of the medicine is carried out constantly during the heat evaporation of the medicine, and the absorbent core is formed. In the heating evaporation used, there is almost no clogging of the absorbent core, and stable heating evaporation is achieved. Further, by using a specific aqueous organic compound to form a volatilization regulator of the aqueous drug for heating vaporization, and by using the adjusted volatilization regulator to constitute the aqueous drug for heating vaporization, the vaporization of the drug during the heating vaporization of the drug Is performed constantly, there is almost no clogging of the liquid absorption core in the heat evaporation using the liquid absorption core, the drug is heated and evaporated evenly over a long period of time, and even in the latter stage of energization, There is no change in composition and no cloudiness occurs in the liquid.
【図1】吸液芯を用いた吸上式加熱蒸散装置の概略図を
示す。FIG. 1 is a schematic view of a wicking type heating evaporation device using a liquid wick.
1 吸液芯 2 芯支持体 3 薬液収容容器 4 環状発熱体 5 支持部 6 支持脚 7 発熱体支持台 1 Liquid absorption core 2 Core support 3 Chemical liquid storage container 4 Annular heating element 5 Supporting part 6 Supporting leg 7 Heating element support base
Claims (4)
水と共に含有する加熱蒸散用水性薬剤において、分子量
が75〜170の水性有機溶剤を6〜60重量%と水を
94〜40重量%とを含有することを特徴とする加熱蒸
散用水性薬剤。1. An aqueous drug for heat evaporation comprising an active ingredient, a heat evaporative drug, together with an organic solvent and water, in an amount of 6 to 60% by weight of an aqueous organic solvent having a molecular weight of 75 to 170 and 94 to 40% by weight of water. An aqueous chemical composition for heat evaporation, comprising:
5〜170の水性有機溶剤を6〜60重量%及び水を9
4〜40重量%を含有する加熱蒸散用水性薬剤を40〜
450℃の温度で加熱して蒸散させることを特徴とする
加熱蒸散方法。2. A heat-evaporable drug as an active ingredient, having a molecular weight of 7
5 to 170 aqueous organic solvent 6 to 60% by weight and water 9
40 to 40% by weight of the aqueous agent for heat evaporation containing 4 to 40% by weight
A heating evaporation method characterized by heating at a temperature of 450 ° C. to evaporate.
系化合物の少なくともいずれか一方を主成分として含有
することを特徴とする加熱蒸散用水性薬剤の揮散性調整
剤。3. A volatilization adjusting agent for an aqueous chemical agent for heat vaporization, which contains at least one of an aqueous diol compound and an aqueous alcohol compound as a main component.
を蒸散させる加熱蒸散用水性薬剤において、水性ジオー
ル系化合物、水性アルコール系化合物の少なくともいず
れか一方を含有させることを特徴とする加熱蒸散用水性
薬剤の揮散性を調整する方法。4. An aqueous drug for heat vaporization for heating a liquid-absorbent wick that has absorbed a liquid chemical to vaporize the drug, containing at least one of an aqueous diol compound and an aqueous alcohol compound. A method for adjusting the volatility of an aqueous chemical for heat evaporation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP09284594A JP3405807B2 (en) | 1993-04-15 | 1994-04-07 | Aqueous chemical for heat evaporation and heat evaporation method and volatility modifier of aqueous chemical for heat evaporation |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11120293 | 1993-04-15 | ||
JP5-111202 | 1993-12-28 | ||
JP5-354569 | 1993-12-28 | ||
JP35456993 | 1993-12-28 | ||
JP09284594A JP3405807B2 (en) | 1993-04-15 | 1994-04-07 | Aqueous chemical for heat evaporation and heat evaporation method and volatility modifier of aqueous chemical for heat evaporation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07316002A true JPH07316002A (en) | 1995-12-05 |
JP3405807B2 JP3405807B2 (en) | 2003-05-12 |
Family
ID=27307129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP09284594A Expired - Fee Related JP3405807B2 (en) | 1993-04-15 | 1994-04-07 | Aqueous chemical for heat evaporation and heat evaporation method and volatility modifier of aqueous chemical for heat evaporation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3405807B2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6620418B1 (en) * | 1999-03-30 | 2003-09-16 | Shiseido Company, Ltd. | Antiseptic/antifungal agent and endermic liniment composition which contains it |
WO2005002632A1 (en) * | 2003-07-07 | 2005-01-13 | Kobayashi Pharmaceutical Co., Ltd. | Fragrance fluid composition for fragrant deodorizing device |
WO2005002633A1 (en) * | 2003-07-07 | 2005-01-13 | Kobayashi Pharmaceutical Co., Ltd. | Fragrance fluid composition for fragrant deodorizing device |
JP2005040594A (en) * | 2003-07-07 | 2005-02-17 | Kobayashi Pharmaceut Co Ltd | Fragrance fluid composition for fragrant deodorizing device |
JPWO2003099343A1 (en) * | 2002-05-27 | 2005-09-22 | アース製薬株式会社 | Volatilization equipment |
EP2364590A1 (en) * | 2010-03-09 | 2011-09-14 | Cognis IP Management GmbH | Biocide compositions comprising valerolactone or its derivatives |
US9265257B2 (en) | 2013-06-26 | 2016-02-23 | Sumitomo Chemical Company, Limited | Aqueous pest control composition |
JP2020114873A (en) * | 2016-01-25 | 2020-07-30 | 大日本除蟲菊株式会社 | Pest control product and pest control method |
WO2021010195A1 (en) | 2019-07-12 | 2021-01-21 | 大日本除蟲菊株式会社 | Insecticidal efficacy enhancer, pest control method, and aqueous insecticide composition for thermal transpiration |
CN114007425B (en) * | 2019-07-12 | 2024-04-26 | 大日本除虫菊株式会社 | Insecticidal efficacy enhancer, method for controlling insect pests, and aqueous insecticidal composition for heat evaporation |
-
1994
- 1994-04-07 JP JP09284594A patent/JP3405807B2/en not_active Expired - Fee Related
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6620418B1 (en) * | 1999-03-30 | 2003-09-16 | Shiseido Company, Ltd. | Antiseptic/antifungal agent and endermic liniment composition which contains it |
JPWO2003099343A1 (en) * | 2002-05-27 | 2005-09-22 | アース製薬株式会社 | Volatilization equipment |
WO2005002632A1 (en) * | 2003-07-07 | 2005-01-13 | Kobayashi Pharmaceutical Co., Ltd. | Fragrance fluid composition for fragrant deodorizing device |
WO2005002633A1 (en) * | 2003-07-07 | 2005-01-13 | Kobayashi Pharmaceutical Co., Ltd. | Fragrance fluid composition for fragrant deodorizing device |
JP2005040593A (en) * | 2003-07-07 | 2005-02-17 | Kobayashi Pharmaceut Co Ltd | Fragrance fluid composition for fragrant deodorizing device |
JP2005040594A (en) * | 2003-07-07 | 2005-02-17 | Kobayashi Pharmaceut Co Ltd | Fragrance fluid composition for fragrant deodorizing device |
JP2005040595A (en) * | 2003-07-07 | 2005-02-17 | Kobayashi Pharmaceut Co Ltd | Fragrance fluid composition for fragrant deodorizing device |
EP2364590A1 (en) * | 2010-03-09 | 2011-09-14 | Cognis IP Management GmbH | Biocide compositions comprising valerolactone or its derivatives |
US9265257B2 (en) | 2013-06-26 | 2016-02-23 | Sumitomo Chemical Company, Limited | Aqueous pest control composition |
JP2020114873A (en) * | 2016-01-25 | 2020-07-30 | 大日本除蟲菊株式会社 | Pest control product and pest control method |
WO2021010195A1 (en) | 2019-07-12 | 2021-01-21 | 大日本除蟲菊株式会社 | Insecticidal efficacy enhancer, pest control method, and aqueous insecticide composition for thermal transpiration |
JPWO2021010195A1 (en) * | 2019-07-12 | 2021-12-09 | 大日本除蟲菊株式会社 | Insecticide efficacy enhancer, pest control method, and aqueous insecticide composition for thermal transpiration |
KR20220002598A (en) | 2019-07-12 | 2022-01-06 | 다이니혼 죠츄기쿠 가부시키가이샤 | Insecticide effect enhancer, pest control method, and aqueous insecticide composition for heat evaporation |
CN114007425A (en) * | 2019-07-12 | 2022-02-01 | 大日本除虫菊株式会社 | Pesticidal efficacy enhancer, method for controlling pests, and aqueous pesticidal composition for heat transpiration |
EP3964068A4 (en) * | 2019-07-12 | 2023-01-11 | Dainihon Jochugiku Co., Ltd. | Insecticidal efficacy enhancer, pest control method, and aqueous insecticide composition for thermal transpiration |
AU2020313634B2 (en) * | 2019-07-12 | 2023-11-09 | Dainihon Jochugiku Co., Ltd. | Insecticidal efficacy enhancer, insect pest control method, and water-based insecticidal composition to be vaporized and diffused by being heated |
TWI829942B (en) * | 2019-07-12 | 2024-01-21 | 日商大日本除蟲菊股份有限公司 | Insecticidal efficacy enhancer, insect pest control method, and aqueous insecticidal composition for thermal vaporization/diffusion |
TWI830684B (en) * | 2019-07-12 | 2024-01-21 | 日商大日本除蟲菊股份有限公司 | Insecticidal efficacy enhancer, insect pest control method, and aqueous insecticidal composition for thermal vaporization/diffusion |
CN114007425B (en) * | 2019-07-12 | 2024-04-26 | 大日本除虫菊株式会社 | Insecticidal efficacy enhancer, method for controlling insect pests, and aqueous insecticidal composition for heat evaporation |
Also Published As
Publication number | Publication date |
---|---|
JP3405807B2 (en) | 2003-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4663315A (en) | Device and method for vaporizing thermally vaporizable composition | |
JP5561663B2 (en) | 匍匐 Pest repellent and repellant method | |
JP5352891B2 (en) | Pest repellent | |
JP6965394B2 (en) | Pest control products and pest control methods | |
JP3405807B2 (en) | Aqueous chemical for heat evaporation and heat evaporation method and volatility modifier of aqueous chemical for heat evaporation | |
JP2001017055A (en) | Extermination of insect pest | |
TWI586274B (en) | Insect pest control product and insect pest control method | |
JP2604239B2 (en) | Liquid absorption wick and chemical evaporation method | |
AU2020313634B2 (en) | Insecticidal efficacy enhancer, insect pest control method, and water-based insecticidal composition to be vaporized and diffused by being heated | |
JP3133761B2 (en) | A method for adjusting the volatility of the heat-evaporated chemical for the absorbent core and the volatility of the heat-evaporated chemical | |
JP2000511165A (en) | Silicone elastomer with insecticidal effect | |
JP3032853B2 (en) | Liquid wick | |
JP3204767B2 (en) | Aqueous drug composition for heat evaporation | |
JP2519669B2 (en) | Anti-clogging agent for liquid absorbent core | |
JPS60233001A (en) | Chemical solution composition for liquid absorbing core | |
JPH08231321A (en) | Suppressant for stinging and biting behavior of insect pest and method for suppressing stinging and biting behavior of insect pest | |
JP2021095413A (en) | Insect pest control product, and insect pest control method | |
JP2000119105A (en) | Chemical composition for heat transpiration and liquid absorbing wick for heat transpiration | |
CN111972430A (en) | Aqueous insecticide composition for heat transpiration, and use for controlling mosquitoes with reduced sensitivity to pyrethroid-based insecticidal component | |
JPH10279402A (en) | Liquid medicine heat transpiration | |
JPH11269008A (en) | Insecticidal incense stick and prevention of migration and dissipation of insecticidal component | |
JP2000103704A (en) | Liquid absorption wick for transpiration by heating | |
JP2022064533A (en) | Aqueous agent for thermal transpiration | |
JPH0768085B2 (en) | Heat transpiration insecticide method | |
JP2665910B2 (en) | Volatile substance container |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090307 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100307 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100307 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110307 Year of fee payment: 8 |
|
LAPS | Cancellation because of no payment of annual fees |